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INTRODUCTION 
 Osteoarthritis (OA) is the most prevalent form of arthritis, affecting 24 million 
people1, with the knee being the most affected joint2.  Osteoarthritis causes decreased 
range of motion (ROM) and cartilage degeneration of the affected joint1.  This results in 
abnormal walking gait and associated difficulty with activities of daily living, such as 
stair descent 1.  Osteoarthritic patients have a longer period of double-support and 
increased ground reaction force during mid stance, indicating there is abnormal knee joint 
loading during gait and OA patients need longer periods of support to ambulate2.  Stair 
descent is a physically demanding task due to increased knee joint loading3.  This 
increased knee joint loading results in knee extensor weakness, and can lead to a 
decreased velocity, as well as an increased stride width, compared to healthy controls4.  
 Total Knee Arthroplasty (TKA) is a surgical intervention that replaces the medial 
and lateral diseased compartments of the knee and is the most widely used intervention 
for restoring knee function to OA patients5.  It has been estimated that approximately four 
million adults in the US over the age of 50 have undergone a TKA procedure6.  At four 
weeks postoperatively, TKA patients reported difficulty rising from a chair and 
descended stairs at a slower pace than those with no difficulty rising from a chair7. 
Previous research shows that 70% of TKA patients demonstrate abnormal moment 
patterns and anterior knee pain, indicating that TKA patients do not all return to full knee 
function by 12 months8.  At 12-months post-operative deficits remained in TKA patients 
for decreased knee flexion angles, and knee extension moments during stance phase 
contributing to a quad avoidance gait compared to controls5.  Similar results for 
decreased knee flexion angles and knee extension moments were found during stair 
descent9,10.  
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 Unicompartmental Knee Arthroplasty (UKA) is a surgical intervention that 
replaces the medial compartment of the knee while a majority of the knee joint 
anatomical structures remain untouched during the surgical procedure, including 
retention of the ACL and PCL11.  Unicompartmental Knee Arthroplasty survivorship is 
comparable to TKA, with both at 88%- 92% ten-years post-operatively12-14.  Using self-
reported questionnaires, previous research suggests UKA patients reported improved 
patient satisfaction on pain and function compared to TKA patients15.  During level 
walking, UKA patients demonstrate similar walking velocities to healthy controls16,17.  
Additionally, when performing downhill walking, UKA patients walked at an increased 
velocity of 15% compared to TKA patients and with similar gait parameters to healthy 
controls17.  
 Based on self-reported assessment questionnaires, 86% of UKA patients were 
satisfied following surgical intervention, compared to only 71% of TKA patients 18.  No 
differences during stair descent in peak knee flexion angle (PKFA), peak knee flexion 
moment (PKFM), and vertical ground reaction force (vGRF) were reported in patients 
undergoing a TKA in one limb and a UKA on the contralateral limb19.  However, TKA 
patients experience a decreased knee extensor strength compared to UKA patients 
following surgery20. 
 The majority of support for UKA comes from patient reported outcomes, rather 
than gait analysis during stair negotiation11,15,18,21.  There is a lack of research evaluating 
sagittal plane knee biomechanics during stair descent in patient’s under-going a TKA or 
UKA for the treatment of OA, compared to age-matched healthy controls.  Therefore, the 
purpose of this study is to compare sagittal plane knee biomechanics in TKA and UKA 
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patients compared to healthy controls.  It is hypothesized that UKA patients will have 
improved knee flexion angle and knee flexion moment compared to TKA patients.   
Additionally, it is hypothesized that UKA patients will exhibit sagittal plane 
biomechanical values more similar to healthy controls.  
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METHODOLOGY 
Research Design 
 A longitudinal design was utilized to investigate the effectiveness of 
Unicompartmental knee arthroplasty (UKA) implant design when compared to total knee 
arthroplasty (TKA) implants and healthy controls.  Biomechanical assessment of 
osteoarthritic (OA) patients during stair negotiation occurred within one-week prior to 
surgery and post-surgery at six-weeks, three-months, six-months and one-year.  Healthy 
control participants completed a single biomechanical assessment and used for 
comparison of biomechanical variables of interest to knee arthroplasty patients. 
Participants 
 Fifty-eight participants were included in this study. The UKA group consisted of 
seven patients (9 knees) compared to nine healthy control knees, and the TKA group 
consisted of 18 patients (24 knees) compared to 24 healthy control knees.  Inclusion 
criteria for all arthroplasty patients consisted of: under 75 years of age, no previous 
history of lower extremity fracture, osteotomy, or joint replacement, undergoing an 
unilateral or bilateral UKA or TKA for the treatment of osteoarthritis, and physically able 
to walk without an aid.  Total knee arthroplasty patients were screened for inclusion for 
this study and randomly assigned to receive either a single radius (SR) 
(GetAroundKnee™, Stryker Orthopedics, Mahwah,NJ) or a multi-radius (MR) implant 
(Balanced Knee® System, Ortho Development Corporation, Draper, UT) design.  All 
UKA patients screened for inclusion received an Oxford Partial Knee Implant (Zimmer 
Biomet Orthopedics, Warsaw, IN).  All TKA and UKA surgeries were performed by the 
same board certified orthopedic surgeon.  Biomechanical assessment of enrolled 
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arthroplasty patients occurred within one week prior to surgery and post-surgery at six-
weeks, three-months, six-months and one-year.  Data was collected on healthy control 
participants in the same manner on the right limb only at a one-time data collection.  
Inclusionary criteria for the controls included: between 55-75 years of age with no 
previous history of heart condition, balance or fainting disorders, Parkinson’s Disease, 
diagnosed neurological disorders, diabetes mellitus, rheumatoid arthritis, osteoarthritis, 
surgery to the hip, knee or ankle or injury or severe knee pain in the last six months.    
 Prior to enrollment in the study, all participants signed informed consent forms 
approved by the Institution’s Human Studies Program.  Once consent was gained, 
participants received an ID number that was used for all data collection sessions and 
paperwork.  All participant data was kept in a filing cabinet in a locked office within the 
Biomechanics Human Performance Lab at the University of Hawaiʻi at Mānoa.  All 
adverse events, such as injury during testing sessions, were monitored and reported to the 
Institutional Review Board in accordance to the reporting criteria.   
Procedures 
All biomechanical analyses was conducted at the University of Hawai‘i Gait 
Laboratory.  Upon arrival at each visit, participants completed The University of 
California at Los Angeles (UCLA) activity questionnaire that asked the participant “to 
circle a number from 1-10 that best described their current activity level” (1-being wholly 
inactive, dependent on others, and cannot leave residence, 10-regularly participates in 
impact sports).  Supplemental questions to be answered by participants consisted of: 1) 
“how does your knee affect your ability to rise from a chair?” (1-“because of my knee I 
cannot rise from a chair” to 4-“my knee does not affect my ability to rise from a chair”) 
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and 2) “are you satisfied with your replacement?” (“yes” or “no”).  Control participants, 
in addition to completing the UCLA activity questionnaire, completed a health 
questionnaire to determine eligibility to participate as a control subject in this study. 
Following completion of the surveys, participant’s height was collected using a wall-
mounted stadiometer (Model 67032, Seca Telescopic Stadiometer, Country Technology, 
Inc., Gays Mills, WI, USA) and body mass was collected using a Detecto certifier scale 
(Webb City Mo, USA).  Shank lengths were recorded as the distance measured from the 
lateral knee joint line to the distal lateral malleolus; 80% of shank length was calculated 
and marked.  These markings served as location points for placement of the hand-held 
dynamometer during knee extensor strength testing, to allow for consistent placement of 
the dynamometer relative to each patient.  
Twenty-nine reflective markers were placed bilaterally over: anterior superior 
iliac spines, posterior superior iliac spines, medial and lateral femoral condyles, medial 
and lateral malleoli, calcanei, base and head of the fifth metatarsals, head of the first and 
second metatarsals and acromioclavicular joints.  Rigid marker arrays were placed 
bilaterally on lateral thighs and shanks.  Single reflective markers were placed over: 
xyphoid process, superior aspect of manubrium at the jugular notch, vertebral spinous 
process of cervical seven, thoracic vertebral spinous process of thoracic ten and the 
inferior angle of the right scapula.  Markers on the medial femoral epicondyle, medial 
malleolus and head of the first metatarsal were used for calibration purposes during a 
static trial only and were removed for stair trials.  
A three-step staircase, with dimensions of an 18 cm step rise, 46 cm step width 
and 28 cm step tread was used for stair negotiation assessment.  Each participant began 
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descending the stairs with a reciprocal foot-fall pattern with the surgical limb contacting 
the ground and second-step.  A handrail was provided for safety but patients were 
instructed not to use it unless balance was compromised.  If the handrail was used, the 
trial was discarded.  A member of the research team was positioned at the bottom of the 
stairs at all times to provide further assistance if needed.  During stair negotiation trials, 
marker positions were collected using a Vicon Nexus motion capture system (Vicon, Inc., 
Centennial, CO).  Two force plates (Advanced Mechanical Technology Incorporated, 
Boston, MA), one embedded flush with the floor and one instrumented within the second 
step of the stairs, were used to collect kinetic data.  Kinematic data was collected at 240 
Hz and time synchronized with kinematic data collected at 960 Hz.  A low-pass 
Butterworth filter was used to filter kinematic data and kinetic data used for calculation 
of external joint moments at a 10 Hz cut-off frequency and ground reaction force data 
was filtered using a 50 Hz cut-off frequency.  Knee flexion angle and knee extension 
moments were reported at 25% and 50% to account for the biphasic pattern that occurred 
during stair descent.  Twenty-five percent represented after heel contact on the force 
plate, and 50% represented the time before toe-off.  Joint moments were calculated using 
inverse dynamics based on filtered marker trajectories and kinetic data.  All joint 
moments were reported as external moments and knee flexion angle values were reported 
as a positive number.  All data was processed with Visual 3D (C-Motion, Inc., 
Germantown, MD).  Due to high intra-subject variability previously reported during stair 
climbing in the OA population, five successful trials were averaged22.   
 Following stair descent trials, bilateral knee extensor muscle strength tests was 
performed using a handheld dynamometer (Hoggan Health Industries, West Jordan, UT).  
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Placement of the dynamometer was at the marked 80% length of the shank and secured in 
place by a strap to ensure constant resistance.  Knee extensor strength was performed 
with the patient seated in a recumbent position with their knee flexed to 65° and their 
trunk extended 130° from the surface of the treatment table with their hands placed on the 
table behind them supporting their trunk in this position.  Participants were instructed to 
build a force over three seconds, holding the maximal force contraction for two seconds.  
Two trials of a three-second maximal effort isometric knee extension contraction was 
completed.  A third trial was completed if the second trial did not measure within 10% 
force output of the first trial.  Verbal encouragement was given to help elicit maximal 
force production by the participant during strength testing.  
Statistical Analysis 
 Data normality was assessed using Shapiro-Wilk Test and Levene’s Test to assess 
homogeneity of variance between groups for biomechanical variables of interest.  
Analysis of variance (ANOVA) was performed to identify significant differences in 
dependent variables between controls, TKA, and UKA groups (p value, F-ratio).  When 
assumptions of ANOVA were violated, e.g. significant Shapiro-Wilk or Levene’s, the 
Mann Whitney U test was utilized for non-parametric analysis (MW p value).  
Frequencies reported for questions: “how does your knee affect your ability to rise from a 
chair?”, and patient satisfaction were reported.  All data was analyzed using SPSS 
Version 22.0 and an alpha level of p<0.05 was used to determine statistical significance.  
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RESULTS 
 
 Patient demographics were not significantly different between groups and are 
listed in table 1.  Fifty-eight patients were included in this study (n=7 UKA, n=18 TKA, 
n=33 healthy controls). 
 
Unicompartmental Knee Arthroplasty v. Total Knee Arthroplasty 
 Seven UKA (2 bilateral, aged 67.9 ± 3.7) patients were compared to 18 TKA (6 
bilateral, aged 64.9 ± 5.0) patients.  Biomechanical variable means and standard 
deviations can be seen in table 2.  
 No spatiotemporal variables or knee extensor strength were significantly different 
between the UKA and TKA patients. The UKA group produced 6.4° greater knee flexion 
angle (KFA) at 25% of stance six-months post-operatively compared to the TKA group 
(MW p=0.015) and 8.7° more at one-year (p=0.001, F-ratio=14.422).  Knee flexion angle 
at 50% of stance six-months post-operatively was 5.5° greater in the UKA patients 
(p=0.05, F-ratio=4.184) and 8.9° greater one-year (p=0.002, F-ratio=11.693).  At six-
months, the UKA generated 0.3 Nm·kg-1 more knee flexion moment (KFM) at 25% of 
stance than the TKA (p=0.012, F-ratio=7.077) and at one-year 0.4 Nm·kg-1 more 
(p=0.004, F-ratio=10.16).  The UKA also demonstrated 0.3 Nm·kg-1 more KFM at 50% 
of stance six-months post-operatively, and 0.4 Nm·kg-1 more at one-year (p=0.003, F-
Table 1. Participant Demographics.
UKA (N=7) CON (N=9) UKA vs. CON TKA (N=18) CON (N=24) TKA vs. CON UKA vs. TKA
Mean (SD) Mean (SD) P Value Mean (SD) Mean (SD) P Value P Value
Age 68.0 (3.7) 68.1 (4.5) 0.948 65.0 (5.0) 63.8 (6.9) 0.564 0.159
Height (m) 1.7 (.09) 1.7 (.08) 0.192 1.7 (.09) 1.7 (.09) 0.462 0.716
Weight (kg) 85.2 (16.4) 86.9 (19.5) 0.851 81.7 (16.0) 80.6 (15.8) 0.82 0.633
UKA, unicompartmental knee arthroplasty; TKA, total compartmental knee arthroplasty.
CON, controls; SD, standard deviation; P ≤ 0.05 significance.
m, meters; kg, kilograms.
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ratio=11.234). Knee extension power was 108.6 W greater in the UKA group one-year 
post-operatively compared to the TKA group (p=0.038, F-ratio=4.794).  
 There was no significant difference between UKA and TKA patients and their 
“how does your knee affect your ability to rise from a chair?” question, and patient 
satisfaction question.  All UKA and TKA patients were satisfied with their implants, and 
at one year were able to rise from their chair. Percent frequencies for patient group 
answers can be seen in table 3. 
Unicompartmental Knee Arthroplasty v. Healthy Controls 
 Seven UKA (2 bilateral, aged 68.0 ± 3.7) patients were compared to nine healthy 
controls (aged 68.1 ± 4.5).  Biomechanics variables means and standard deviations can be 
seen in table 4.  
The controls were 1.4 seconds faster to descend the stairs pre-operatively (MW 
p≤0.001), 2.4 seconds faster at six-weeks (MW p≤0.001), 0.4 seconds faster at three-
months (MW p=0.003), and 0.3 seconds faster at six-months (p≤0.001, F-ratio=16.974) 
than the UKA group.  Knee extensor strength was not statistically significantly at any 
time point.  Unicompartmental knee arthroplasty (UKA) patients produced 9.6° greater 
KFA at 25% of stance one-year post-operatively (p=0.002, F-ratio=13.323) than the 
controls.  Knee flexion angle at 50% of stance at one-year was 10.3° greater in the UKA 
patients (p=0.003, F-ratio=13.369) than the controls. 
 Pre-operatively, the controls produced 3.6 N·kg-1 more of ground reaction force 
on the first force plate during stair descent than the UKA (MW p=0.031).  The controls 
also produced 0.5 Nm·kg-1 greater KFM at 25% of stance pre-operatively (p=0.025, F-
ratio=6.254) and at six-weeks post-operatively (p=0.012, F-ratio=8.075) than the UKA. 
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The controls generated 0.3 Nm·kg-1 greater KFM at 50% of stance than the UKA at six-
weeks post-operatively (p=0.025, F-ratio=6.12).  Knee extension power was 202.0 W 
greater in the controls pre-operatively (p=0.007, F-ratio=9.887), 203.5 W greater six-
weeks post-operatively (p=0.006, F-ratio =9.962), and 152.1 W greater three-months 
post-operatively (p=0.038, F-ratio =5.139) than the UKA group. 
Total Knee Arthroplasty v. Healthy Controls 
 Eighteen TKA (6 bilateral, aged 64.9 ± 5.0) patients were compared to 24 healthy 
controls (aged 63.8 ± 6.9).  Biomechanics variables means and standard deviations can be 
seen in table 5.  
The controls were more quickly to descend the stairs than the TKA pre-
operatively by 1.5 seconds (MW p≤0.001), 1.7 seconds faster at six-weeks (MW 
p≤0.001), 1.5 seconds faster at three-months (MW p≤0.001), 1.8 seconds faster at six 
months (MW p≤0.001), and 1.1 seconds faster at one-year (MW p≤0.001).  Controls 
demonstrated 4.0° greater KFA at 25% of stance post-operatively at six-weeks (p=0.016, 
F-ratio =6.419), three-months (p=0.009, F-ratio =7.437), and six-months (MW p=0.041) 
than the TKA.  
 The controls produced 2.1 N·kg-1 more ground reaction force on the first force 
plate of stair descent pre-operatively (MW p=0.007), 2.6 N·kg-1 more six-weeks post-
operatively (p≤0.001, F-ratio=16.922), and 1.8 N·kg-1 more three-months post-
operatively (MW p=0.012). The controls on the second force plate of stair decent 
produced 2.0 N·kg-1 more pre-operatively (p=0.003, F-ratio=9.9), 2.8 N·kg-1 more at six 
weeks (p≤0.001, F-ratio=18.313), and 1.8 N·kg-1 more at three-months (p=0.017, F-
ratio=6.222).  Knee flexion moment at 25% of stance was 0.6 Nm·kg-1 greater in controls 
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pre-operatively (p≤.001, F-ratio =46.053), 0.7 Nm·kg-1 greater at six-weeks (p≤.001, F-
ratio =63.626), 0.6 Nm·kg-1 greater at six-months (p≤.001, F-ratio =40.931), and 0.5 
Nm·kg1 more at one-year (p≤.001, F-ratio=32.112) than the TKA. Controls also 
generated 0.6 Nm·kg-1 greater KFM at 50% of stance pre-operatively (MW p≤0.001), 0.5 
Nm·kg-1 greater at six-weeks (MW p≤0.001), 0.5 Nm·kg-1 more at six-months (p≤0.001, 
F-ratio=38.199), and 0.4 Nm·kg-1 more at one-year (p≤0.001, F-ratio=24.547) than TKA.   
Knee extension power was 185.1 W more in controls pre-operatively (MW p≤0.001), 
215.0 W at six-weeks post-operatively (MW p≤0.001), 204.7 W at three-months (MW 
p≤0.001), and 182.4 W at six-months (MW p<0.001), and 147.71 W greater at one-year 
(p≤0.001F-ratio=17.317) than TKA patients. 
 The controls were stronger by 19.7 pounds of force (lbs.) in knee extensor 
strength than the TKA patients pre-operatively (p=0.015, F-ratio=6.416) and 35.2 lbs. at 
six-weeks (p≤0.001, F-ratio=22.171), 27.3 lbs. at three-months (p≤0.001, F-
ratio=17.642), 23.7 lbs. at six-months (p=0.003, F-ratio=9.813), and 17.5 lbs. at one-year 
(p=0.027, F-ratio=5.225) post-operatively.  
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Table 2. Descriptive Measures of Biomechanical Variables Over Time for UKA and TKA Groups.
Spatiotemporal Pre-Operative 6-Weeks
Group N Mean (SD) 95% CI P Value N Mean (SD) 95% CI P Value
Total Time on Stairs (s) UKA 7 2.5 (1.2) 1.4-3.7 0.199 d 9 3.5 (3.9) 0.5-6.5 0.754 d
TKA 22 2.6 (3.1) 1.2-4.0 12 2.9 (3.8) 0.5-5.3
Kinematics
KFA at 25% of stance (°) UKA 7 24.0 (8.1) 16.5-31.5 0.761 c 9 26.6 (3.8) 23.7-29.6 0.194 c
TKA 22 25.2 (9.4) 21.1-29.4 12 24.4 (3.7) 22.0-26.8
KFA at 50% of stance (°) UKA 7 33.5 (13.9) 20.6-46.4 0.354 c 9 30.7 (3.0) 28.4-33.0 0.583 c
TKA 22 29.1 (9.9) 24.7-33.4 12 31.9 (5.8) 28.2-35.6
Kinetics 
KFM at 25% of stance  (Nm/kg) UKA 7 0.9 (0.4) 1.3-0.5 0.296 c 9 0.9 (0.4) 1.2-0.6 0.693 d
TKA 22 0.7 (0.4) 0.9-0.5 12 0.7 (0.2) 0.8-0.6
KFM at 50% of stance (Nm/kg) UKA 7 1.0 (0.4) 1.4-0.7 0.122 d 9 1.0 (0.3) 1.2-0.8 0.095 c
TKA 22 0.8 (0.4) 1.0-0.7 12 0.9 (0.2) 1.0-0.8
GRF 1 (N/kg) UKA 7 12.2 (3.4) 9.1-15.4 0.438 d 9 13.5 (4.1) 10.4-16.6 0.808 d
TKA 22 13.1 (2.8) 11.9-14.4 12 12.7 (2.0) 11.4-13.9
GRF 2 (N/kg) UKA 7 14.1 (2.8) 11.5-16.6 0.598 c 9 15.7 (4.1) 12.6-18.9 0.262 d
TKA 22 14.7 (2.6) 13.5-15.8 13 13.9 (2.2) 12.6-15.2
Knee Power Extension (W) UKA 7 274.4 (86.5) 354.4-194.4 0.409 d 9 272.9 (120.8) 365.7-180.1 0.345 d
TKA 22 255.8 (118.8) 308.4-203.1 12 225.9 (88.0) 281.8-170.0
Strength
Knee Extensor Strength  (lbs.) UKA 9 81.9 (37.8) 52.9-110.9 0.237 c 9 70.9 (26.9) 50.2-91.5 0.068 c
TKA 24 67.1 (28.9) 54.9-79.3 20 51.5 (24.7) 40.0-63.1
Spatiotemporal 3-Months 6-Months
Total Time on Stairs (s) UKA 9 1.5 (0.3) 1.3-1.7 0.263 d 9 1.4 (0.2) 1.3-1.5 0.773 d
TKA 21 2.7 (3.4) 1.1-4.2 23 3.0 (4.2) 1.2-4.8
Kinematics
KFA at 25% of stance (°) UKA 9 27.6 (5.8) 23.2-32.1 0.139 c 9 30.6 (6.2) a 25.9-35.4 0.015 d
TKA 21 24.0 (6.1) 21.2-26.8 23 24.2 (6.8) 21.3-27.2
KFA at 50% of stance (°) UKA 9 32.5 (5.8) 28.0-36.9 0.395 c 9 35.8 (7.3) a 30.2-41.4 0.050 c
TKA 21 29.8 (8.4) 26.0-33.6 23 30.3 (6.7) 27.4-33.2
Kinetics 
KFM at 25% of stance  (Nm/kg) UKA 9 1.1 (0.4) 1.3-0.8 0.819 c 9 1.1 (0.2) a 1.3-0.9 0.012 c
TKA 22 1.0 (0.9) 1.4-0.6 23 0.8 (0.3) 0.9-0.7
KFM at 50% of stance (Nm/kg) UKA 9 1.1 (0.3) 1.4-0.9 0.924 c 9 1.2 (0.2) a 1.3-1.0 0.020 c
TKA 21 1.1 (1.0) 1.6-0.6 23 0.9 (0.3) 1.0-0.8
GRF 1 (N/kg) UKA 9 14.3 (4.0) 11.2-17.4 0.982 d 9 14.6 (3.7) 11.8-17.4 0.509 d
TKA 20 13.4 (2.6) 12.2-14.6 23 14.3 (2.6) 13.2-15.4
GRF 2 (N/kg) UKA 9 17.0 (3.3) 14.5-19.5 0.150 d 8 16.9 (2.9) 14.5-19.4 0.368 d
TKA 21 14.8 (3.1) 13.4-16.2 22 16.1 (2.5) 15.0-17.2
Knee Power Extension (W) UKA 9 324.3 (133.0) 426.5-222.0 0.077 d 9 356.4 (142.9) 466.2-246.5 0.078 d
TKA 20 236.2 (127.1) 295.7-176.7 23 258.5 (84.1) 294.8-222.1
Strength
Knee Extensor Strength  (lbs.) UKA 9 67.7 (35.6) 40.4-95.1 0.480 d 9 86.8 (38.0) 57.6-116.0 0.112d
TKA 22 59.4 (18.6) 51.2-67.7 23 63.1 (27.1) 51.3-74.8
18 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Descriptive Measures of Biomechanical Variables Over Time for UKA and TKA Groups.
Spatiotemporal 1-Year
Group N Mean (SD) 95% CI P Value
Total Time on Stairs (s) UKA 7 1.3 (0.2) 1.1-1.4 0.120 d
TKA 19 2.3 (3.3) 0.7-3.9
Kinematics
KFA at 25% of stance (°) UKA 8 35.8 (5.8) b 30.9-40.6 0.001 c
TKA 18 27.1 (5.2) 24.5-29.7
KFA at 50% of stance (°) UKA 7 41.7 (5.7) a 36.4-47.0 0.002 c
TKA 19 32.7 (6.0) 29.9-35.6
Kinetics 
KFM at 25% of stance  (Nm/kg) UKA 8 1.3 (0.4) a 1.6-1.0 0.004 c
TKA 19 0.9 (0.3) 1.0-0.8
KFM at 50% of stance (Nm/kg) UKA 7 1.4 (0.3) a 1.7-1.1 0.003 c
TKA 19 1.0 (0.2) 1.1-0.9
GRF 1 (N/kg) UKA 7 15.7 (3.5) 12.4-18.9 0.427 d
TKA 19 14.3 (2.2) 13.2-15.4
GRF 2 (N/kg) UKA 7 18.5 (3.0) 15.7-21.2 0.096 c
TKA 19 16.6 (2.3) 15.5-17.7
Knee Power Extension (W) UKA 8 401.8 (154.0) a 530.5-273.0 0.038 c
TKA 19 293.1 (100.1) 341.4-244.9
Strength
Knee Extensor Strength  (lbs.) UKA 9 90.0 (37.8) 60.9-119.0 0.096 c
TKA 21 69.3 (26.5) 57.2-81.3
UKA, unicompartmental knee arthroplasty; TKA, total knee arthroplasty.
SD, standard deviation; CI, confidence interval. 
KFA, knee flexion anlge; (°), degrees; KFM, knee flexion moment.
Nm/kg, newton-meters per kilogram; (N/kg), newtons per kilogram.
GRF 1, force plate in stairs; GRF 2, force plate in ground; (W), watts; (s), second; (lbs.), pounds.
a , significant difference (P ≤ 0.05).
b, significant difference (P ≤ 0.001).
c , ANOVA.
d, Mann Whitney U-test.
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Table 3. Percentages of UKA and TKA Patients' Satisfied, and "Chair Rise" Ability.
UKA TKA UKA TKA UKA TKA UKA TKA UKA TKA
(N=7) (N=18) (N=7) (N=14) (N=7) (N=16) (N=7) (N=17) (N=7) (N=14)
Satisfied Patient 100% n/a 100% n/a 100% n/a 100% 83.30% 100% 77.8%
Chair Rise Question
"2" 42.9% 44.4% 14.3% 5.6% 14.3% 5.6% 14.3% 11.1% 14.3% 5.6%
"3" 14.3% 44.4% 57.1% 44.4% 0% 44.4% 0% 22.2% 14.3% 0.0%
"4" 14.3% 11.1% 28.6% 27.8% 85.7% 38.9% 85.7% 61.1% 71.4% 72.2%
Missed 22.20% 11.10% 5.50% 22.20%
UKA, unicompartmental knee arthroplasty; TKA, total knee arthroplasty.
"2", Because of my knee, I can only rise from a chair if I use my hands and arms to assist.
"3", I have pain when rising from the seated position, but it does not affect my ability to rise from the seated position.
"4", My knee does not affect my ability to rise from a chair.  
Pre-Operative 6-Weeks 3-Months 6-Months 1-Year
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Table 4. Descriptive Measures of Biomechancial Variables Over Time in UKA and Control Groups.
Spatiotemporal Pre-Operative 6-Weeks
Group N Mean (SD) 95% CI P Value N Mean (SD) 95% CI P Value
Total Time on Stairs (s) UKA 7 2.5 (1.2) b 1.4-3.7 0.000 d 9 3.5 (3.9) b 0.5-6.5 0.000 d
CON 9 1.1 (0.1) 1.0-1.2 9 1.1 (0.1) 1.0-1.2
Kinematics
KFA at 25% of stance (°) UKA 7 24.0 (8.1) 16.5-31.5 0.523 c 9 26.6 (3.8) 23.7-29.6 0.829 c
CON 9 26.2 (5.1) 22.2-30.1 9 26.2 (5.1) 22.2-30.1
KFA at 50% of stance (°) UKA 7 33.5 (13.9) 20.6-46.4 0.674 c 9 30.7 (3.0) 28.4-33.0 0.760 c
CON 9 31.3 (5.6) 27.1-35.6 9 31.3 (5.6) 27.1-35.6
Kinetics 
KFM at 25% of stance  (Nm/kg) UKA 7 0.9 (0.4) a 1.3-0.5 0.025 c 9 0.9 (0.4) a 1.2-0.6 0.012 c
CON 9 1.3 (0.3) 1.6-1.1 9 1.3 (0.3) 1.6-1.1
KFM at 50% of stance (Nm/kg) UKA 7 1.0 (0.4) 1.4-0.7 0.142 d 9 1.0 (0.3) a 1.2-0.8 0.025 c
CON 9 1.4 (0.3) 1.6-1.1 9 1.4 (0.3) 1.6-1.1
GRF 1 (N/kg) UKA 7 12.2 (3.4) a 9.1-15.4 0.031 d 9 13.5 (4.1) 10.4-16.6 0.063 d
CON 9 15.8 (1.9) 14.3-17.3 9 15.8 (1.9) 14.3-17.3
GRF 2 (N/kg) UKA 7 14.1 (2.8) 11.5-16.6 0.068 c 9 15.7 (4.1) 12.6-18.9 0.546 d
CON 9 16.6 (2.4) 14.8-18.5 9 16.6 (2.4) 14.8-18.5
Knee Power Extension (W) UKA 7 274.4 (86.5) a 354.4-194.4 0.007 c 9 272.9 (120.8) a 365.7-180.1 0.006 c
CON 9 476.4 (151.1) 592.5-360.3 9 476.4 (151.1) 592.5-360.3
Strength
Knee Extensor Strength  (lbs.) UKA 9 81.9 (37.8) 52.9-110.9 0.984 c 9 70.9 (26.9) 50.2-91.5 0.363 c
CON 9 82.2 (24.4) 63.5-100.9 9 82.2 (24.4) 63.5-100.9
Spatiotemporal 3-Months 6-Months
Total Time on Stairs (s) UKA 9 1.5 (0.3) a 1.3-1.7 0.003 d 9 1.4 (0.2) b 1.3-1.5 0.001 c
CON 9 1.1 (0.1) 1.0-1.2 9 1.1 (0.1) 1.0-1.2
Kinematics
KFA at 25% of stance (°) UKA 9 27.6 (5.8) 23.2-32.1 0.581 c 9 30.6 (6.2) 25.9-35.4 0.114c
CON 9 26.2 (5.1) 22.2-30.1 9 26.2 (5.1) 22.2-30.1
KFA at 50% of stance (°) UKA 9 32.5 (5.8) 28.0-36.9 0.683 c 9 35.8 (7.3) 30.2-41.4 0.162 c
CON 9 31.3 (5.6) 27.1-35.6 9 31.3 (5.6) 27.1-35.6
Kinetics 
KFM at 25% of stance  (Nm/kg) UKA 9 1.1 (0.4) 1.3-0.8 0.095 c 9 1.1 (0.2) 1.3-0.9 0.120 c
CON 9 1.3 (0.3) 1.6-1.1 9 1.3 (0.3) 1.6-1.1
KFM at 50% of stance (Nm/kg) UKA 9 1.1 (0.3) 1.4-0.9 0.112c 9 1.2 (0.2) 1.3-1.0 0.133 c
CON 9 1.4 (0.3) 1.6-1.1 9 1.4 (0.3) 1.6-1.1
GRF 1 (N/kg) UKA 9 14.3 (4.0) 11.2-17.4 0.332 c 9 14.6 (3.7) 11.8-17.4 0.222 d
CON 9 15.8 (1.9) 14.3-17.3 9 15.8 (1.9) 14.3-17.3
GRF 2 (N/kg) UKA 9 17.0 (3.3) 14.5-19.5 0.666 d 8 16.9 (2.9) 14.5-19.4 0.963 d
CON 9 16.6 (2.4) 14.8-18.5 9 16.6 (2.4) 14.8-18.5
Knee Power Extension (W) UKA 9 324.3 (133.0) a 426.5-222.0 0.038 c 9 356.4 (142.9) 466.2-246.5 0.103 c
CON 9 476.4 (151.1) 592.5-360.3 9 476.4 (151.1) 592.5-360.3
Strength
Knee Extensor Strength  (lbs.) UKA 9 67.7 (35.6) 40.4-95.1 0.330 c 9 86.8 (38.0) 57.6-116.0 0.730 d
CON 9 82.2 (24.4) 63.5-100.9 9 82.2 (24.4) 63.5-100.9
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Table 4. Descriptive Measures of Biomechancial Variables Over Time in UKA and Control Groups.
Spatiotemporal 1-Year
Group N Mean (SD) 95% CI P Value
Total Time on Stairs (s) UKA 7 1.3 (0.2) 1.1-1.4 0.114d
CON 9 1.1 (0.1) 1.0-1.2
Kinematics
KFA at 25% of stance (°) UKA 8 35.8 (5.8) a 31.0-40.6 0.002 c
CON 9 26.2 (5.1) 22.2-30.1
KFA at 50% of stance (°) UKA 7 41.7 (5.7) a 36.4-46.9 0.003 c
CON 9 31.3 (5.6) 27.1-35.6
Kinetics 
KFM at 25% of stance  (Nm/kg) UKA 8 1.3 (0.4) 1.6-1.0 0.861 c
CON 9 1.3 (0.3) 1.6-1.1
KFM at 50% of stance (Nm/kg) UKA 7 1.4 (0.3) 1.7-1.1 0.767 c
CON 9 1.4 (0.3) 1.6-1.1
GRF 1 (N/kg) UKA 7 15.7 (3.5) 12.4-18.9 0.837 d
CON 9 15.8 (2.0) 14.3-17.3
GRF 2 (N/kg) UKA 7 18.5 (3.0) 15.7-21.2 0.193 c
CON 9 16.6 (2.4) 14.8-18.5
Knee Power Extension (W) UKA 8 401.8 (154.0) 530.5-273.0 0.330 c
CON 9 476.4 (151.1) 592.5-360.3
Strength
Knee Extensor Strength  (lbs.) UKA 9 90.0 (37.8) 60.9-119.0 0.612 c
CON 9 82.2 (24.4) 63.5-100.9
UKA, unicompartmental knee arthroplasty; CON, controls.
SD, standard deviation; CI, confidence interval. 
KFA, knee flexion anlge; (°), degrees; KFM, knee flexion moment.
Nm/kg, newton-meters per kilogram; (N/kg), newtons per kilogram.
GRF 1, force plate in stairs; GRF 2, force plate in ground; (W), watts; (s), second; (lbs.), pounds.
a , significant difference (P ≤ 0.05).
b, significant difference (P ≤ 0.001).
c , ANOVA.
d, Mann Whitney U-test.
22 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Descriptive Measures of Biomechanical Variables Over Time in TKA and Control Groups.
Spatiotemporal Pre-Operative 6-Weeks
Group N Mean (SD) 95% CI P Value N Mean (SD) 95% CI P Value
Total Time on Stairs (s) TKA 22 2.6 (3.1) b 1.2-4.0 0.000 d 12 2.9 (3.8) b 0.4-5.3 0.000 d
CON 24 1.2 (0.1) 1.1-1.2 24 1.2 (0.1) 1.1-1.2
Kinematics
KFA at 25% of stance (°) TKA 22 25.2 (9.4) 21.1-29.4 0.344 d 12 24.4 (3.7) a 22.0-26.8 0.016 c
CON 24 28.4 (4.8) 26.4-30.4 24 28.4 (4.8) 26.4-30.4
KFA at 50% of stance (°) TKA 22 29.1 (9.9) 24.7-33.4 0.113d 12 31.9 (5.8) 28.2-35.6 0.497 d
CON 24 33.2 (4.2) 31.4-34.9 24 33.2 (4.2) 31.4-34.9
Kinetics 
KFM at 25% of stance  (Nm/kg) TKA 22 0.7 (0.4) b 0.9-0.5 0.000 c 12 0.7 (0.2) b 0.8-0.6 0.000 c
CON 24 1.4 (0.3) 1.5-1.2 24 1.4 (0.3) 1.5-1.2
KFM at 50% of stance (Nm/kg) TKA 22 0.8 (0.4) b 1.0-0.7 0.000 d 12 0.9 (0.2) b 1.0-0.7 0.000 d
CON 24 1.4 (0.3) 1.5-1.3 24 1.4 (0.3) 1.5-1.3
GRF 1 (N/kg) TKA 22 13.1 (2.8) a 11.9-14.4 0.007 d 12 12.7 (2.0) b 11.4-13.9 0.000 c
CON 24 15.2 (1.7) 14.5-15.9 24 15.2 (1.7) 14.5-15.9
GRF 2 (N/kg) TKA 22 14.7 (2.6) a 13.5-15.8 0.003 c 13 13.9 (2.2) b 12.6-15.2 0.000 c
CON 24 16.7 (1.7) 15.9-17.4 24 16.7 (1.7) 15.9-17.4
Knee Power Extension (W) TKA 22 255.8 (118.8)b 308.4-203.1 0.000 d 12 225.9 (88.0) b 281.8-170.0 0.000 d
CON 24 440.8 (126.4) 494.2-387.5 24 440.8 (126.4) 494.2-387.5
Strength
Knee Extensor Strength  (lbs.) TKA 24 67.1 (28.9) a 54.9-79.3 0.015 c 20 51.5 (24.7) b 40.0-63.1 0.000 d
CON 24 86.8 (24.8) 76.3-97.2 24 86.8 (24.8) 76.3-97.2
Spatiotemporal 3-Months 6-Months
Total Time on Stairs (s) TKA 21 2.7 (3.4) b 1.1-4.2 0.000 d 23 3.0 (4.2) b 1.2-4.8 0.000 d
CON 24 1.2 (0.1) 1.1-1.2 24 1.2 (0.1) 1.1-1.2
Kinematics
KFA at 25% of stance (°) TKA 21 24.0 (6.1) a 21.2-26.8 0.009 c 23 24.2 (6.8) a 21.3-27.2 0.041 d
CON 24 28.4 (4.8) 26.4-30.4 24 28.4 (4.8) 26.4-30.4
KFA at 50% of stance (°) TKA 21 29.8 (8.4) 26.0-33.6 0.152 d 23 30.3 (6.7) 27.4-33.2 0.209 d
CON 24 33.2 (4.2) 31.4-34.9 24 33.2 (4.2) 31.4-34.9
Kinetics 
KFM at 25% of stance  (Nm/kg) TKA 22 1.0 (0.9) 1.4-0.6 0.061 c 23 0.8 (0.3) b 0.9-0.7 0.000 c
CON 24 1.4 (0.3) 1.5-1.2 24 1.4 (0.3) 1.5-1.2
KFM at 50% of stance (Nm/kg) TKA 21 1.1 (1.0) 1.6-0.6 0.160 c 23 0.9 (0.3) b 1.0-0.8 0.000 c
CON 24 1.4 (0.3) 1.5-1.3 24 1.4 (0.3) 1.5-1.3
GRF 1 (N/kg) TKA 20 13.4 (2.6) a 12.2-14.6 0.012 d 23 14.3 (2.6) 13.2-15.4 0.142 c
CON 24 15.2 (1.7) 14.5-15.9 24 15.2 (1.7) 14.5-15.9
GRF 2 (N/kg) TKA 21 14.8 (3.1) a 13.4-16.3 0.017 c 22 16.1 (2.5) 15.0-17.2 0.218 d
CON 24 16.7 (1.7) 15.9-17.4 24 16.7 (1.7) 15.9-17.4
Knee Power Extension (W) TKA 20 236.2 (127.1) b 295.7-176.7 0.000 d 23 258.5 (84.1) b 294.8-222.1 0.000 d
CON 24 440.8 (126.4) 494.2-387.5 24 440.8 (126.4) 494.2-387.5
Strength
Knee Extensor Strength  (lbs.) TKA 22 59.4 (18.6) b 51.2-67.7 0.000 c 23 63.1 (27.1) a 51.3-74.8 0.003 c
CON 24 86.8 (24.8) 76.3-97.2 24 86.8 (24.8) 76.3-97.2
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Table 5. Descriptive Measures of Biomechanical Variables Over Time in TKA and Control Groups.
Spatiotemporal 1-Year
Group N Mean (SD) 95% CI P Value
Total Time on Stairs (s) TKA 19 2.3 (3.3) b 0.7-3.9 0.000 d
CON 24 1.2 (0.1) 1.1-1.2
Kinematics
KFA at 25% of stance (°) TKA 18 27.1 (5.2) 24.5-29.7 0.415 c
CON 24 28.4 (4.8) 26.4-30.4
KFA at 50% of stance (°) TKA 19 32.7 (6.0) 29.8-35.6 0.660 d
CON 24 33.2 (4.2) 31.4-34.9
Kinetics 
KFM at 25% of stance  (Nm/kg) TKA 19 0.9 (0.3) b 1.0-0.8 0.000 c
CON 24 1.4(0.3) 1.5-1.2
KFM at 50% of stance (Nm/kg) TKA 19 1.0 (0.2) b 1.1-0.9 0.000 c
CON 24 1.4 (0.3) 1.5-1.3
GRF 1 (N/kg) TKA 19 14.3 (2.2) 13.2-15.4 0.096 d
CON 24 15.2 (1.7) 14.5-15.9
GRF 2 (N/kg) TKA 19 16.6 (2.3) 15.5-17.7 0.887 c
CON 24 16.7 (1.7) 15.9-17.4
Knee Power Extension (W) TKA 19 293.1 (100.1) b 341.4-244.9 0.000 c
CON 24 440.8 (126.4) 494.2-387.5
Strength
Knee Extensor Strength  (lbs.) TKA 21 69.3 (26.5) a 57.2-81.3 0.027 c
CON 24 86.8 (24.8) 76.3-97.2
TKA, total knee arthroplasty; CON, controls.
SD, standard deviation; CI, confidence interval. 
KFA, knee flexion anlge; (°), degrees; KFM, knee flexion moment.
Nm/kg, newton-meters per kilogram; (N/kg), newtons per kilogram.
GRF 1, force plate in stairs; GRF 2, force plate in ground; (W), watts; (s), second; (lbs.), pounds.
a , significant difference (P ≤ 0.05).
b, significant difference (P ≤ 0.001).
c , ANOVA.
d, Mann Whitney U-test.
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DISCUSSION 
 The main finding of this study was that the UKA patients demonstrated more 
favorable biomechanics, loaded their knees more, and were faster at descending stairs 
compared to the TKA patients, and when compared to their respective control groups.  
Stair descent values between the UKA and TKA patients are similar to previous research 
showing no significant difference at eight-weeks post-operatively for biomechanical 
variables during gait20.  Patients undergoing UKA demonstrated significantly better 
outcomes starting at six-months and continuing to one-year post-operatively with greater 
knee angles and moments at 25% and 50% of stance when compared to TKA patients.  
Similar to previous research showing UKA patients walked 15% faster than TKA patients 
during downhill walking, UKA patients in this study were able to descend stairs more 
quickly than the TKA patients17.  At six-months and one-year post-operatively both UKA 
and TKA patients were satisfied with their implants, and were able to rise from a chair.  
Some patients still reported pain or needing arms for assistance with rising from a chair, 
but those frequencies were lower than pain free and assistance free rising from a chair.  
 The UKA patients demonstrated similar biomechanical variables at all time 
points.  At one-year post-operatively the UKA patients exceeded knee angles at both 25% 
and 50% of stance when compared to healthy controls.  Knee moments were similar 
between groups as early as three-months post-operatively, and this is supported with 
previous literature finding that 70% of UKA patients had normal biphasic 
flexion/extension moment patterns28.  Ground reaction force, knee extension power and 
knee extensor strength were also similar between the UKA patients and healthy controls 
at all time points.  The UKA were less quick to descend stairs than controls up to six-
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months post-operatively, and returned to similar values at one-year post-operatively; this 
is similar to research concluding UKA had improved spatiotemporal values than TKA16.  
Previous research concluding superior outcomes in UKA has been limited to gait analysis 
or patient reported questionnaires, not stair descent, specifically.  
 Deficits during stair descent were present in the TKA patients when compared to 
their healthy controls at all time points for several biomechanical variables of interest.  
The TKA patients demonstrated decreased knee angles at six-weeks, three-months and 
six-months post-operatively than the healthy controls, which is similar to findings in 
literature5.  Smaller knee moments were produced by the TKA patients pre-operatively, 
six-weeks, six-months and one-year post-operatively than the healthy controls, and this is 
similar to previous research concluding that only 23% of TKA had normal extension 
moment patterns during gait3.  There were decreased ground reaction forces six-weeks, 
three-months and six-months post-operatively when compared to controls.  The TKA 
patients at all time points produced less knee extension power and knee extensor strength 
when compared to their controls.  Only knee angles and ground reaction force returned to 
values similar to controls one-year post-operatively.  
 Several limitations were present in this study.  There were unequal sample sizes in 
the UKA and the TKA groups, and only two of the seven UKA patients received bilateral 
implants compared to six of the 18 TKA.  Some patients were not present at every data 
collection, making unequal sample sizes between the data collections.  This could be due 
to the convenience of getting to the biomechanics gait laboratory for the patients.  The 
small sample size in the UKA patients could have attributed to the non-parametric 
analysis that were analyzed.  The non-parametric Mann-Whitney U test found additional 
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significant variables than the ANOVA analyses.  Another factor were the differences in 
rehabilitation programs between the UKA and TKA patients.  Rehabilitation programs 
were not standardized between patients due to them being completed at different clinics, 
and this may have impacted the post-surgical biomechanical variables during stair 
descent.  Patella resurfacing was performed on all TKA patients, and the UKA patients 
did not have patella resurfacing.  The difference in resurfacing could have affected the 
proprioception of the TKA patients and their ability in returning to similar control values.  
Future studies should involve equal sample sizes between UKA and TKA groups, as well 
as equal comparisons for patients with bilateral operations.  Controlling these factors 
would allow for more accurate results for post-surgical outcomes.  Overall, further 
analysis should be done with a larger UKA sample size to allow for more accurate 
comparison during stair descent.  
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CONCLUSION 
 UKA patients demonstrated more optimal stair descent biomechanics than TKA 
patients at both six-months and one-year post-surgery.  Additionally, UKA patients were 
more similar to their control group than the TKA patients were to their control group at 
one-year post-surgery.  The UKA patients were not significantly different than their 
controls at the six-months and one-year time points, whereas the TKA showed deficits up 
to one-year post-operatively.  Both UKA and TKA patient groups were satisfied with 
their implants, in spite of biomechanical differences suggesting improved outcomes in 
UKA patients.  Results of this study support the UKA implant as the preferred surgical 
intervention for OA patients, when indicated, over the TKA implant. 
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REVIEW OF LITERATURE 
Osteoarthritis 
 Osteoarthritis is the most prevalent form of arthritis, and most commonly 
affecting the knee joint2.  There are approximately 24 million people living with 
osteoarthritis (OA)1, and four million adults living that underwent a total knee 
arthroplasty (TKA) procedure6.  As people get older there is a decrease in knee 
extensor strength4, and decreased knee range of motion (ROM)1, which is important 
for descending stairs.   
 Weinstein et al. 6 identified that there is an increase in total knee arthroplasty 
(TKA) in younger adults and an increased life expectancy, resulting in more 
individuals living with TKA longer than before.  The Osteoarthritis Policy (OAPol) 
Model was used to take into account data on TKA incidence, and estimate the 
prevalence of primary and revision TKA among adults in the United States (US).  The 
2009 US census data was used.  In adults over 50 years of age, there was 4.2% with 
TKA, and 11.5% were diagnosed with symptomatic knee osteoarthritis (OA). 
Approximately four million adults in the US over the age of 50 were estimated to be 
living with TKA, and 536,100 living with revised TKA.   
 Chen et al.2 used 3D Vicon optoelectronic motion analysis, six infrared 
cameras, and reflective markers to analyze sagittal plane knee mechanics during 
gait in elderly (n=15, aged 63.5±11.3), OA (n=20, aged 65.5±9.3), and healthy 
controls (n=20, aged 21.7±4.5).  Walking is an important task for independent living 
in the elderly population.  The OA patients had longer double-limb support than the 
elderly and healthy control groups, and the elderly had longer double-limb support 
29 
 
than the controls.  There was decreased ground reaction force(GRF) during heel 
strike and toe off, and increased GRF during midstance in the OA group.  The OA 
patients had abnormal knee joint loading during gait, and gait characteristics when 
compared to elderly and healthy controls.  
 A study by Ko et al. 4 performed 3D gait analysis patterns and knee strength 
in 190 participants that were placed in three groups based on age: Middle age (32-
57, N=27), old age (58-78, N=125), and oldest age (79-93, N=38).  Participants were 
asked to walk at preferred speed and fastest speed without running.  Knee extensor 
strength was measured using Kinetic Communicator isokinetic dynamometer.  The 
Spline Regression Model and Generalized Linear Regression models were used for 
statistical analysis.  Maximum isokinetic knee concentric strength was significantly 
lower for the oldest age group compared to middle age.  The old age group had 
slower gait speed and wider stride width, and decreased concentric knee strength. 
So, there is a steady decline in gait speed and increased stride width with age, which 
can be a result of decreased isokinetic knee extensor strength.  
 There are approximately 24 million knee osteoarthritis (OA) patients in 
Japan6.  Igawa et al.,1 investigated lower extremity joint kinematics and kinetics 
during stair descent in 12 individuals; four patients with early stage unilateral knee 
OA (n=1 male, aged 76 ± 7), and eight healthy (aged 69 ± 6) controls were used.  The 
patients’ severity of OA was determined with Kellgren-Lawrence grading system.  
Kinematic and kinetic data was collected with 3D motion analysis.  Patients were 
asked to descend a five-step staircase, at a self-selected speed without assistive 
devices.  Data was collected on the dominant limb on the healthy controls, and the 
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involved limb on the OA patients.  The Mann-Whitney-U test was used for data 
analysis.  Knee joint angle of knee OA patients was less than the healthy controls 
during 12-23% of the gait cycle.  Knee ROM was less than that of healthy controls 
during stair descent, and there was decreased eccentric quadriceps contraction.  
There was a significant difference in knee flexion moments in favor of healthy 
controls.  The ratio of contribution of knee joint power of OA was less than healthy 
controls.  Results of this study indicate that the decreased knee joint angle, ROM and 
moment could be causes of difficult stair descent in OA patients.  
 In conclusion, there are 24 million people living with OA1,4, and this can get 
treated with a knee arthroplasty procedure to improve patient function.  As people 
get older there is decreased knee extensor strength and decreased stride length 
during gait2; as well as decreased knee ROM and eccentric quadriceps contraction 
during stair descent1.  
Total Knee Arthroplasty and Patient Satisfaction 
 Total Knee Arthroplasty (TKA) is a surgical intervention for the treatment of 
knee osteoarthritis (OA).  Self reported patient questionnaires like the Total Knee 
Function Questionnaire (TKFQ), the Short Form-12 (SF-12), Oxford Knee Score 
(OKS), Scottish Index of Multiple Deprivation (SIMD), and Knee Society Score (KSS) 
collect patient reported satisfaction on knee function postoperatively 8,24,25.  Patients 
are generally satisfied with their implant, and some were dissatisfied with their 
implant because of increased knee stiffness, swelling of the knee, decreased activity, 
and problems with activity’s of daily living (ADL’s)24.  
31 
 
 Noble et al.24 determined which factors contributed to patient satisfaction 
with TKA.  Two-hundred-fifty-three patients (n=148 women, average age 68.1 
years), at least one year post operation completed a self-survey of Total Knee 
Function Questionnaire (TKFQ).  An analysis of variance (ANOVA), univariate 
logistic model, and multivariate logistic model were used.  Seventy five percent of 
patients were satisfied, 11% were neutral, and 14% were dissatisfied.  Factors of 
decreased satisfaction were aged 60 to 75 years, knee stiffness once per week, 
swelling of the knee once per week, use of analgesics at least once per day for pain. 
Fourteen percent of satisfied patients said they were less active post operative, and 
32% of dissatisfied said they were less active post operative.  Forty five percent of 
satisfied patients had problems with activities of daily living (ADL’s), and 71% of 
dissatisfied patients had problems with ADL’s.  The dissatisfied patients were 
significantly different that the satisfied patients for function for stretching, leg 
strengthening exercises, turning/pivoting, moving laterally, dancing, gardening and 
squatting. 
 Scott et al.25 identified predictors of dissatisfaction in 177 TKA in 157 
patients less than 50 years of age (n=177 women, average age 50).  Three cruciate 
retaining TKA implants were used.  Patient outcomes were collected preoperative 
and 12 month postoperative at preoperative and 12-months postoperative.  The 
results of the 177 TKA were compared to 2831 TKA’s in patients greater than 55 
years of age.  The Short Form-12 (SF-12), Oxford Knee Score (OKS), Scottish Index of 
Multiple Deprivation (SIMD), Knee Society Score (KSS), ROM, and radiographs were 
collected.  Univariate analysis was completed with the student’s t test, Mann-
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Whitney U test, One way-analysis of variance (ANOVA), Chi-squared test, Fisher’s 
exact test, Pearson’s correlation, and Multivariate Binary Logistic Regression were 
used.  Seventy two percent (133/177) patients were satisfied, and 25% (44/177) 
were dissatisfied with their TKA.  The mean SF-12 decreased in both satisfied and 
dissatisfied groups.  The OKS increased in both TKA groups.  Post-operative 
predictors of dissatisfaction were the SF-12, OKS, and knee flexion less than 90°.  
 In conclusion self reported patient questionnaires are used to determine TKA 
satisfaction.  Patients dissatisfaction was the result of knee stiffness, knee swelling, 
decreased function, and problems with ADL’s24.  Despite these dissatisfied factors, 
patients were overall satisfied with their implant.  Noble et al. concluded that out of 
253 TKA patients, 75% were satisfied and 14% were dissatisfied.  Scott et al. 
concluded that out of 177 patients that underwent a TKA procedure, 72% were 
satisfied and 25% were dissatisfied with their implant25.  
Total Knee Arthroplasty and Gait Analysis 
 The evaluation of a TKA implant can be done with three dimensional gait 
analysis, timed 30-second chair rise tests, and isokinetic strength tests5,7,8.  Three 
dimensional gait analysis provides variables to determine the success of the 
implant.  There is a decrease in knee flexion angles and knee flexion moments one 
year post-operative, compared to participants pre-operative values5.   When 
evaluating the ability to rise from a chair, TKA patients that needed their hands and 
arms to assist them when rising from a chair descended stairs slower than patients 
that did not need their hands and arms for assistance7.   The evaluation of 
descending stairs is also used9,10.  Research shows decreased peak knee flexion 
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angle when descending stairs9, and there was an abnormal knee moment pattern in 
correlation with the decreased knee flexion angles10.  
 Smith et al.8 studied if abnormal external flexion and extension moment 
patterns are present after TKA and if there are pre-operative identifiable factors. 
Thirty four patients (41 TKA knees, aged 69 ± 7 years), and 20 healthy controls (67 
± 7 years) were included in this study.  Data was collected pre-operative and at 12 to 
18 months post-operative.  The Knee Society Clinical Rating System, Knee pain scale, 
and knee pain diagram were used at each clinical evaluation.  Gait analysis was 
completed with a six camera Vicon 370 motion analysis, and a walk way embedded 
with two force plates.  Patients were fitted with reflective markers, and walked five 
to eight trials at a self-selected pace.  The Mann-Whitney U-test, paired t-test, 
Levene’s test, Bonferroni correction for non-parametric statistics, two factor 
repeated measures ANOVA, and multiple linear and regression models were used.  
The Knee society score and Knee Society Function score increased significantly pre-
operative to post-operative.  The Knee pain scale significantly decreased pre-
operative to post-operative.  At follow up 41.5% of TKA patients had anterior knee 
pain, and increased their self-selected walking pace.  The healthy controls had 
greater single limb support, less double limb support, and smaller stance phase 
times than TKA patients.  Thirty percent of TKA patients had a biphasic external 
knee flexion and extension moment pattern, 40% had a flexor moment pattern, and 
30% had an extensor moment pattern.  The indicators for post-operative anterior 
knee pain were peak external flexor moment during early midstance, and knee 
flexion angle at heel strike.  There was a significant interaction between change in 
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peak terminal stance knee extension moment and presence of post-operative 
anterior knee pain.  
 Li et al. 5 quantified differences in muscle function during walking between 
14 bilateral TKA patients (aged 67 ± 7 yrs.) to 40 age matched healthy controls.  
Data was collected 12 months postoperative, with an eight camera three 
dimensional gait analysis.  The patients were fitted with 15 reflective markers, and 
the walkway was embedded with two force platforms.  A two-way and one-way 
analysis of variance (ANOVA) were used.  TKA patients had decreased knee flexion 
angles, and knee extension moments during early stance compared to controls. 
There was decreased knee extension moment produced by the vasti muscles and 
rectus femoris during early stance.  The peak knee flexion angles during stance was 
9.7° for TKA patients, compared to 16.2° in healthy controls.  The peak knee 
extension moment was 0.25 N m/kg in TKA patients, compared to 0.42 N m/kg in 
healthy controls.  The decreased knee flexion during gait caused a decreased knee 
extension moment created by GRF at the knee, which decreased the demand on the 
vastus muscles to generate a resistive knee extension moment.  
 A study by Nyland et al. 7 did a retrospective, posttest design that evaluated 
the self-reported chair-rise ability ratings for indicating patient readiness to begin 
safe stair climbing.  Thirty one patients (n=22 females, aged 63 ± 6.4) scheduled for 
TKA for the treatment of unilateral knee OA were included in the study.  Patients 
completed at three to four weeks post-operation the Knee Outcome Survey-Activity 
of Daily Living Scale (KOS-ADLS), a 30-second chair-rise test, a timed stair ascent 
and descent test, and knee extensor and flexor torque strength with an isokinetic 
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dynamometer.  The multivariate general linear model analysis of variance, pearson 
product moment correlations, and Post hoc tukey tests were used for statistical 
analysis.  Participants were placed into three groups based on their response to 
their ability to rise from a chair.  Twelve responded, “Because of my knee, I can only 
rise from a chair if I use my hands and arms to assist” (group one); 12 responded, 
“Because of my knee, I can only rise from a chair if I use my hands and arms to 
assist”(group two); seven responded, “my knee does not affect my ability to rise 
from a chair” (group three).  Group three had greater knee flexion torque, 
performed more sit-to-stand repetitions, greater peak knee extensor torque, and 
scored higher KOS-ADLS than groups one and two.  Groups three and two 
descended stairs quicker than group one.  Indicating that the ability to rise from a 
chair correlates to the ability to descend stairs.  
 Bjerke et al.9 compared peak knee flexion during stair descent in 23 patients 
with TKA on one knee to their contralateral knee, and to 23 healthy age matched 
controls.  TKA patients were post-operative from one to three years. All subjects 
performed six stair trials at a self-selected pace.  Peak passive knee flexion, joint 
position sense were collected, and isokinetic quad strength were collected.  An eight 
camera system and three dimensional analysis were used for whole body 
kinematics.  The Kolmogorov-Smirnov, paired sample t-test, one way ANOVA, 
Pearson Correlation, and Multiple Regression Analysis were used for statistical 
analysis.  Quad peak isokinetic torque was lower in the TKA side compared to the 
contralateral side and the healthy controls. There was decreased peak knee flexion 
during stair descent in the TKA leg compared to their contralateral leg.  
36 
 
 McLelland et al.10 investigated knee flexion and extension patterns during 
stair ascent and descent in 40 TKA patients (n=13 bilateral TKA) to a healthy 
population (N=33).  TKA patients were postoperative 12 to 18 months.  The 
American Knee Society Score (KSS) was collected at 12 months postoperative, and 
Total Knee Function Questionnaire (TKFQ) was collected during motion analysis.  
Motion analysis was collected with an eight camera Vicon MX3.  Patients walked a 
10-meter walk way embedded with two force plates, to a two step stair case 
embedded with one force plate on the first step.  The patients were fitted with 14-
reflective markers, and five trials were collected on each limb.  Euler’s angles were 
used for joint kinematics, and knee flexion angles and moments in the sagittal plane 
were analyzed.  Hierarchical analysis, step wise discriminant function analysis, and 
independent sample t-test were used for statistical analysis.  Of the 40 TKA patients, 
21 completed stair descent and 26 completed stair ascent.  Stair descent is more 
difficult than stair ascent.  Patients with an abnormal knee moment pattern 
descended the stairs with less knee flexion and lower peak knee flexion than healthy 
controls.  Peak knee flexion angles and moments were not significantly different 
between patients with bilateral TKA and unilateral TKA. 
 In conclusion three dimensional analysis of gait and stair descent provide 
kinetic and kinematic variables to be used to evaluate a TKA implant.  When 
evaluating gait and stair descent there is a decrease in peak knee flexion angles, and 
a decrease in isokinetic quad strength5,9.  Meaning TKA post-operative patients have 
decreased knee function when compared to healthy controls9,10.   
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Unicompartmental Knee Arthroplasty and Patient Satisfaction and Survivorship 
 An alternative to Total Knee Arthroplasty (TKA) is Unicompartmental Knee 
Arthroplasty (UKA).  Unicompartmental Knee Arthroplasty is indicated for those 
with anteromedial knee osteoarthritis, intact cruciate ligaments, and full lateral 
cartilage thickness12.  The Knee Injury Osteoarthritis Outcome score, American Knee 
Society Score, Oxford Knee Score, University of California Los Angeles (UCLA) 
activity score, Forgotten Joint Score, and clinical radiographs were used to assess 
the survivorship and satisfaction of a UKA implant12-14,18,21,26.  In longitudinal and 
retrospective studies the UKA survivorship 10 years post-operatively was 88% to 
91.2%12,14, and in patients greater than 60 years of age a survivorship of 96%13.  
Indicating it produces favorable functional and durable outcomes in OA patients 
greater than or less than 60 years of age13.  
 Emerson et al. 12 conducted a longitudinal follow up in 213 medial UKA 
patients (173 knees, n=95 men, average aged 67), to evaluate the survivorship of the 
implant and patient reported outcomes.  The American Knee Society Score (AKSS), 
and anteroposterior and lateral radiographs were collected at six weeks, six months, 
one year, and every two years after that.  Survival Analysis was completed with a life 
table method and Microsoft Excel Macros.  The average follow up was at 10 years, 
and survivorship of UKA was 88%.  The mean preoperative AKSS Knee Score was 
50, and increased to 93 postoperative.  Twenty patients (n=20 knees) were revised 
at an average of 6.2 years for lateral compartmental osteoarthritis (LCOA).  
 Medial UKA implants are generally used on those greater than 60 years of 
age.  Price et al. 13 compared the 10 year survivorship and clinical outcomes of the 
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Oxford UKA in patients greater than or equal to 60 years of age (n=512), and less 
than 60 years of age (n=52)(average age 70).  A life table using revision as the end 
point was used for survivorship, and the Hospital for Special Surgery (HSS) Knee 
Score was used for clinical outcomes.  Statistics were completed with the log Rank 
test, and Student’s t-test.  Twenty four knees were revised (n=20, ≥60 yrs of age, 
n=4 <60 yrs of age).  The 10-year survivorship for ≥ 60 age group was 96%, 
compared to 91% for <60 age group.  The 10-year postoperative HSS knee score 
was 52 in <60 age group, and 86 in ≥60 age group.  The 10-year ROM was 116° in 
<60 age group, and 111° in ≥60 age group.  The UKA implant produces functional 
and durable outcomes in those greater than or less than 60 years of age.  
 Clement et al.14 did a retrospective study on 28 women (average age 71), and 
21 men (average age 68) that underwent Oxford Phase-3 UKA.  Data was collected 
post-operatively at six weeks, six months, and every year after.  The Oxford Knee 
Score (OKS), Visual Analog Scale for pain and satisfaction, and radiographs were 
collected.  The Kaplan-Meir Survival Analysis and Multiple Logistic Regression were 
used.  The average follow up was seven years (7.2).  At nine years the survival rate 
was 91.2%, and only four knees underwent revision.  
 Streit et al.26 evaluated clinical and radiological findings preoperative and 
postoperatively at three and 12 months, three years, and every five years after in 
107 knees (average aged 57, 25-60 yrs).  The Functional and objective American 
Knee Society Score (AKSS-F, AKSS-O) and Oxford Knee Score (OKS), and 
anteroposterior radiographs were collected.  The University of California Los 
Angeles (UCLA) activity score was collected at final follow up.  The Kaplan-Meir 
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survival analysis determined at five years postoperative there was 97% UKA 
survival.  Five knees were revised, and 66 patients were very pleased with their 
UKA.  Ninety-two knees were viewed radiographs, and five developed OA in the 
lateral compartment.  The OKS, AKSS-O, UCLA score, and knee flexion angle and 
ROM all improved significantly at final follow up.  Streit et al.26 concluded that at five 
years (5 ± 1.6 yrs) follow up UKA implant had high survival and patient satisfaction.   
 In conclusion UKA is a favorable alternative to TKA as it has approximately 
90% survivorship at 10 years follow up12-14,26.  Also, 66 UKA patients out of 107 
knees were very satisfied with their implant based on the KSS, OKS, and UCLA 
questionnaires26.   
Unicompartmental Knee Arthroplasty V. Total Knee Arthroplasty Patient Reported 
Outcomes 
 Patient reported outcomes are used to compare UKA and TKA implants.  
Surveys used are the Knee Injury Osteoarthritis Outcome Score (KOOS), Knee 
Society Scoring System, Forgotten Joint Score, Western Ontarion and McMaster 
Universities Osteoarthritis Index (WOMAC), High Flexion Knee Score (HFKS), and 
EuroQol-5D (EQ-5D) were used11,15,18,21.   At two years post-operatively UKA 
patients had higher function scores than TKA for rising from a chair and descending 
stairs, and 86% were satisfied with their UKA compared to 71% satisfaction for 
their TKA18.  
 The study by Fabre-Aubrespy et al. 21did a retrospective study to analyze 
UKA in 101 patients (aged 75 to 90) undergoing fixed-bearing UKA and were 
matched to 101 patients receiving primary mobile bearing UKA.  Clinical outcomes 
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were collected with the Knee Injury Osteoarthritis Outcome Score (KOOS), Knee 
Society Scoring System, and Forgotten Joint Score; and radiographs were collected 
pre-operatively, post-operatively and at follow up21.  Chi-square tests, and a paired t 
test were used for data analysis.  At an average follow up of eight years, the UKA 
group had higher KOOS scores for symptoms, pain, activities of daily living, and 
activity and quality of life when compared to TKA group.  At an average follow up of 
16 years, there was no significant difference between UKA and TKA group for the 
number of revision surgeries.  UKA can be an alternative to TKA patients based on 
having higher functional and forgotten joint scores than TKA.  However, previous 
research states that UKA has more revision surgeries than TKA.  
 Kim et al.18 compared 100 UKA patients and 416 TKA patients satisfaction 
and reported outcomes using the Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC) to assess pain, stiffness and function, the propensity 
score matching (PSM) questionnaire, the Forgotten Joint Score (FJS), and high 
flexion knee score (HFKS).  Patient outcomes were assessed at one and two years 
post-operatively.  All TKA patients had four implants used, and UKA had three 
implants used.  The Chi-square test, and the Wilcoxon signed-rank test was used for 
data analysis.  There was a significant difference in the FJS score and HFKS score at 
two years post-operation with UKA having a higher score than TKA.  The UKA had 
higher function scores on the HFKS for UKA than TKA for questions going over 
descending stairs, or rising from a chair.  The patient satisfaction had 86% 
satisfaction for UKA, when compared to 71% for TKA.  
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 Lombardi et al.11 questioned if UKA compared to TKA for durability, 
incidence of complications and manipulations, recovery, postoperative clinical 
function, patient perceived outcomes, and return to sport and return to work.  
Previous research shows UKA has survivorship of 10 years like that of TKA, when 
the mobile-bearing UKA became available in 200427.  There were 115 medial UKAs 
compared to 115 TKAs.  Clinical outcomes were collected at six weeks 
postoperatively, using the Knee Society (KS) clinical rating system and Lower 
Extremity Activity Scale.  A non-paired, two-tailed Student t test, and Pearson’s Chi-
square test were used.  Seven UKA and three TKA patients had revision surgeries. 
Seven TKAs underwent manipulation, compared to zero UKA.  Hemoglobin 
concentration was higher, hospital stays were shorter and had greater ROM, and 
could walk further distances on discharge for UKA compared to TKA.  At six weeks 
UKA had more ROM than TKA, and although both groups had similar KS scores, the 
UKA group had higher functional scores. At final follow up the UKA had higher ROM, 
but improvement in both groups was similar.  UKA is a favorable surgical device for 
function and the treatment of anteromedial osteoarthritis of the knee.  
 Lygre et al.15 compared pain and function at least two years post-operation 
for TKA or UKA in 1344 participants (n=972, TKA).  The Knee Injury and 
Osteoarthritis Outcome Score (KOOS), and EuroQol-5D (EQ-5D) were used.  The 
idependent-samples Student t test, Pearson chi-square test, multiple logistic 
regression, multiple linear regression, and the Bonferroni correction method were 
used.  When comparing UKA to TKA there was significant differences on the KOOS 
for function in daily living, function in sport and recreation in favor of UKA.  There 
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was no significant difference for improved quality of life between UKA and TKA.  
The UKA and TKA patients experienced pain and function differently, with ROM 
being more favorable for UKA.  UKA patients may have better function with bending 
the knee and stability due to the intact cruciate ligaments.  
 In conclusion patient reported outcomes are in favor of UKA when compared 
to TKA.  There is increased knee range of motion, function when descending stairs 
and rising from a chair, and greater satisfaction in UKA patients11,15,18,21.  
Unicompartmental Knee Arthroplasty V. Total Knee Arthroplasty Gait Analysis 
 Unicompartmental knee arthroplasty (UKA) patients and TKA patients are 
analyzed with gait assessment, treadmills embedded with force plates, fresh frozen 
cadavers, or a two camera optoelectronic digitizer system16,17,19,20,23,28.  When 
patients undergo the UKA procedure on one limb and the TKA implant on the 
contralateral limb, there is no significant difference between knee extension 
strength and sagittal knee moments20.  However, when treadmills embedded with 
force plates were used 92% of healthy controls were classified as UKA patients16, 
and that 70% of UKA patients had a normal biphasic flexion/extension moment 
patterns at the knee28. 
 A study by Jung et al. 19 compared knee kinematics of six patients (n=4 
females, aged 65.0 ± 7.5) during stair negotiation in patients with TKA on one limb 
and UKA on their contralateral limb.  Each patient performed five continuous stair 
negotiation trials at a comfortable pace (average follow up 34.3 ± 11.7 months).  The 
Nonparametric Friedman test was used to test for significance.  There was 
significantly greater knee flexion angle, vertical GRF, and knee joint moments during 
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descent than ascent which indicates stair descent requires more knee function than 
stair ascent.  In this study, no differences were reported between the TKA and UKA 
limb for knee flexion, knee flexion moments or GRF during stair descent. 
 Braito et al. 20 used a prospective comparative design to analyze gait in 15 
UKA and 17 TKA patients post-operatively.  Outcomes were collected preoperatively 
and eight weeks postoperatively using three-dimensional (3D) gait analysis and 
knee extensor torque.  Statistical analysis was completed with a multivariate 
analysis of variance, and the Hotelling-Spur test.  At eight weeks postoperatively, 
they reported TKA patients had a greater decrease in knee extensor torque than 
UKA, however both exhibited a decrease in strength compared to preoperative.   
Both UKA and TKA groups had decreased knee extension when walking, and the 
sagittal knee moments (extension/flexion) had no significant differences between 
surgical groups.  They concluded that at eight weeks postoperatively there was no 
significant difference in gait analysis between TKA and UKA groups.  
 Unicompartmental knee arthroplasty can be a more favorable surgery for 
young or middle aged patients that are more athletic and expect more function.  
Patil et al.23 tested if UKA returned the knee to normal knee function in simulated 
stair climbing in cadavers.  Six, fresh frozen cadaver, left knees, were included in this 
study (aged 73 to 89).  There was significant difference for tibial rotation between 
the tricompartmental replacement and the intact knee.  The current-generation 
fixed-bearing unicompartmental design with low conformity was used, and knee 
kinematics during flexion after the unicompartmental implant were similar to the 
intact knee.  Meaning, the unicompartmental implant can return patients close to 
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normal knee function.  The anterior cruciate ligament being removed did not affect 
the integrity of the unicompartmental design.  
 Wiik et al. 17 analyzed downhill walking on a treadmill embedded with force 
plates in TKA (n=14), UKA (n=19) and healthy controls (n=19).  Patient reported 
outcomes (Oxford Knee Score, UCLA, EuroQol5,  EuroQol) and temporospatial gait 
parameters were collected.  The one way ANOVA, post hok Tukey test, independent 
t test, and Chi squared test were used for statistical analysis.  The UKA and TKA 
patients both had increased stride width when compared to healthy controls.  The 
UKA patients walked 15% faster than TKA patients, and TKA patients had decreased 
stride length than the UKA group.  Overall, UKA patients had more similar gait 
parameters to the healthy controls than TKA group.  
 Jones et al.16 tested if a decision tree would classify the gait of healthy 
controls (n=121) more similar to UKA (n=12) or TKA (n=12) patients.  A decision 
tree differentiated between the gait of UKA and TKA patients, using gait parameters, 
and multiple walking velocities up to their maximum walking speed, to determine 
which group was more classified as healthy controls.  Gait analysis was performed 
with a treadmill embedded with force plates.  All participants walked on the 
treadmill for six minutes, and then speed was increased at 0.5 km/h until a 
maximum walking speed was reached.  Temporospatial gait parameters and vertical 
ground reaction force were collected at 10s speed and 100 Hz.  Oxford knee scores 
were collected during gait analysis.  A program written in Matlab designed eight 
trees to be used.  The output of the tree was a binary prediction for if the patient 
was more similar to UKA or TKA.  One-hundred-eleven healthy controls were 
45 
 
classified as UKA (92%), six were classified as TKA (5%), and four were inconclusive 
(3%)16.  The maximum walking speed of UKA matched that of healthy controls (2.2 
m/s), whereas TKA had a significantly decreased maximum walking speed (1.6 
m/s).  Since there was 92% classified as UKA this supports the theory that intact 
cruciate ligaments, and unaffected lateral tibiofemoral and patellofemoral 
compartments result in improved physiological gait.  
 Chassin et al.28 evaluated if the retention of the ACL in UKA patients avoid 
gait adaptations that have been documented in TKA.  Ten patients (n=7 males, aged 
60 to 80), at an average follow up of 19 months post operation completed this study.  
Limb alignment was determined with standing radiographs, and motion 
measurements were collected with a two-camera optoelectronic digitizer system.  
Limb motion was collected based on six points, and a force plate was embedded in 
the middle of a 10-meter walkway. The external moments of flexion/extension, 
adduction/abduction, and internal/external rotation of the hip, knee and ankle were 
used 28.  The Fisher’s exact test was used for significance.  Seven UKA patients (70%) 
maintained normal biphasic pattern of flexion/extension moments about the knee.  
The stance phase moments changed from external flexion, to extension, and back to 
flexion.  Two UKA patients had an extension pattern, in which the extension moment 
was consistent through the stance phase.  This is favorable to research by 
Andriacchi et al. 3 that found 23% of TKA patients that had normal flexion/extension 
moment patterns.  
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 In conclusion gait analysis with treadmills revealed similar gait patterns to healthy 
controls in UKA patients compared to TKA patients16,17. This study determined if 
biomechanical analysis of stair descent show similar results.  
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APPENDIX A: RESEARCH SUBJECT INFORMATION AND CONSENT FORM 
 
INFORMED CONSENT 
To Participate in a Research Study 
 
Department of Kinesiology and Rehabilitation Science, University of Hawaii at Manoa 
1337 Lower Campus Road, PE/A Complex Rm. 231, Honolulu, HI 96822 
Phone: 808-956-7606 
 
I. INVESTIGATORS 
Principal Investigators: Cris Stickley, PhD, ATC  
 
Investigators: Elizabeth Parke, MS, ATC 
   
 
II. TITLE 
 Biomechanical Analysis of Level Walking and Stair Climbing Tasks 
Across a Lifespan.       
 
III. INTRODUCTION 
 The following information is being provided to help you decide if you would 
like to participate in this study.  This form may have words that you do not 
understand.  If you have questions, please ask us.  The purpose of this study is to 
evaluate biomechanical variables during level walking and stair climbing tasks in a 
healthy control population. 
 
IV. DESCRIPTION OF PROCEDURES 
 You will be asked to report to the University of Hawaii at Manoa Gait Lab 
(Sherriff 100) for a one-time data collection.  The entire visit will take 
approximately 60 minutes.   
When you arrive at the Gait Lab measurements about your body will be taken and 
you will be asked to perform the following tasks:  
 (1) Complete a health history questionnaire as well as a physical activity 
questionnaire 
 (2) Walk for 6 meters at a various speed multiple times,  
 (3) Walk up and down stairs at a comfortable speed 5 times, and  
 (4) push into stationary objects (fixed dynamometer) with your leg for three 
seconds for  
 two different leg movements to measure lower leg strength.   
  
V. RISKS 
 Due to the physical activity involved, there is a slight risk of injury.  You may 
also have some discomfort, muscle cramping or soreness during or after test 
sessions.  Although we have people to assist you and handrails in place during the 
stair climbing task, there is a slight chance of falling during the test.  There is a very 
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remote chance of cardiac arrest and/or death.  These risks are comparable to your 
routine activities of daily living.   
 The investigators of this study are NATABOC certified athletic trainers and 
First Aid/CPR/AED trained.  In the event of any physical injury from the research, 
only immediate and essential medical treatment is available including an AED.  First 
Aid/CPR and a referral to a medical emergency room will be provided.  In the event 
of any emergency incidence outside the lab as a result of this research, contact your 
medical doctor and inform the principal investigator, Cris Stickley, PhD, ATC, at 513-
259-4666 or Elizabeth Parke, MS, ATC at 336-402-3816.  You should understand 
that if you are injured in the course of this research process that you alone will be 
responsible for the costs of treating your injuries. 
You cannot participate in this study if you are pregnant because the 
information collected during the walking test may not accurately represent your 
normal walking characteristics.  If you are unaware that you are pregnant, 
participation in this study will result in no more danger to the mother or fetus than 
normal activities of daily living.  However, if you think you might be pregnant during 
the course of this data collection, you must inform the researchers, and you will be 
excluded from study participation. 
 
VI. BENEFITS 
 You may not receive direct/immediate benefits.  However, you will obtain 
information regarding your walking and running gait upon requests.  
 
VII. COMPENSATION 
 No compensation will be given to patients throughout this study, however, a 
parking fee of five dollars will be reimbursed when the patients arrives at data 
collection with a receipt.  Reimbursement will only be given to for data collections 
the patient is present. 
 
VIII. CONFIDENTIALITY 
 Your research records will be confidential to the extent permitted by law.  
Agencies with research oversight, such as The University of Hawaii Committee on 
Human Studies, have the right to review research records. 
 An identification number will be used to identify you during the study, which 
will be known only to you and study personnel.  In addition, all data and subject 
(identity) information will be kept under lock and key in the Department of 
Kinesiology and Rehabilitation Science at the University of Hawaii at Manoa.  These 
materials will be permanently disposed of in a period not longer than 5 years.  You 
will not be personally identified in any publication arising from this study.  Personal 
information about your test results will not be given to anyone without your written 
permission.   
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IX. CERTIFICATION 
 I certify that I have read and I understand the foregoing, that I have been 
given satisfactory answers to my inquiries concerning the project procedures and 
other matters and that I have been advised that I am free to withdraw my consent 
participation and to discontinue participation in the project or activity at any time 
without prejudice. 
 I herewith consent to participate in this project with the understanding that 
such consent does not waive any of my legal rights, nor does it release the principal 
investigator or institution or any employee or agent thereof from liability for 
negligence.  
 I attest that I am not currently limited from full participation in my chosen 
sport due to injury. 
 I attest that I do not believe that I am currently pregnant. 
 
 If you have any questions related to this study, please contact any of the 
principal investigators: Cris Stickley at 513-259-4666 or Elizabeth Parke, MS, ATC, 
at 336-402-3816 at any time.   
 
_________________________________________                                             
Participant’s Printed Name 
              
_________________________________________        ______________ 
Signature of Participant              Date 
 
_________________________________________      _______________ 
Witness Signature      Date 
 
  If you cannot obtain satisfactory answers to your questions, or have complaints about your 
treatment in this study, please contact: Committee on Human Subjects, University of Hawai’i at 
Manoa, 1960 East-West Rd., Biomed Bldg. Ste. B-104, Honolulu, Hawaii 96822, Phone (808) 956-
5007. 
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RESEARCH SUBJECT INFORMATION AND CONSENT FORM 
 
 
TITLE: Biomechanical Analysis of the Oxford 
Unicompartmental Knee Implant Design During Level 
Walking and Stair Negotiation 
 
 
PROTOCOL NO.: 2016-007 
  
 
SPONSOR: Cris Stickley, PhD, ATC 
 Honolulu, Hawaii 
 United States 
 
INVESTIGATOR: Cass Nakasone, M.D. 
 888 South King Street 
  Honolulu, Hawaii 96813 
 United States 
 
 
STUDY-RELATED 
PHONE NUMBER(S): Cass Nakasone, M.D. 
808-522-4000 
 
Cris Stickley PhD, ATC  
808-956-3798 
 
 
This consent form may contain words that you do not understand.  Please ask the 
study doctor or the study staff to explain any words or information that you do not 
clearly understand.  You may take home an unsigned copy of this consent form to 
think about or discuss with family or friends before making your decision. 
 
SUMMARY 
 
You are being asked to be a participant in a research study.  The purpose of this 
consent form is to help you decide if you want to be in the research study.  Please 
read this consent form carefully.  To be in a research study you must give your 
informed consent.  “Informed consent” includes: 
• Reading this consent form 
• Having the study doctor or study staff explain the research study to you 
• Asking questions about anything that is not clear, and 
• Taking home an unsigned copy of this consent form.  This gives you time to 
think about it and to talk to family or friends before you make your decision. 
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You should not join this research study until all of your questions are answered. 
 
Things to know before deciding to take part in a research study: 
• The main goal of a research study is to learn things to help patients in the 
future. 
• The main goal of regular medical care is to help each patient. 
• No one can promise that a research study will help you. 
• Taking part in a research study is entirely voluntary.  No one can make you 
take part. 
• If you decide to take part, you can change your mind later on and withdraw 
from the research study. 
• The decision to join or not join the research study will not cause you to lose 
any medical benefits.  If you decide not to take part in this study, your doctor 
will continue to treat you. 
• Parts of this study may involve standard medical care.  Standard care is the 
treatment normally given for a certain condition or illness. 
• After reading the consent form and having a discussion with the research 
staff, you should know which parts of the study are experimental 
(investigational) and which are standard medical care. 
• Your medical records may become part of the research record.  If that 
happens, your medical records may be looked at and/or copied by the 
sponsor of this study and government agencies or other groups associated 
with the study. 
 
After reading and discussing the information in this consent form you should know: 
• Why this research study is being done; 
• What will happen during the research; 
• Any possible benefits to you; 
• The possible risks to you; 
• How problems will be treated during the study and after the study is over. 
 
If you take part in this research study, you will be given a copy of this signed and 
dated consent form. 
 
PURPOSE OF THE STUDY 
 
The purpose of this study is to compare the function of patients with the Oxford 
partial knee implant design during level walking and stair negotiation tasks. 
 
Approximately 20 people will participate in this study. 
 
PROCEDURES 
 
52 
 
If you decide to participate in this study you will be receiving per the physician’s 
protocol the Oxford partial knee implant which is approved by the FDA for the type 
of surgery you are having and will be used according to their approved indication. 
 
You will be asked to report to the University of Hawaii at Manoa, Kinesiology and 
Rehabilitation Science Laboratory (Gait Lab) (Sherriff 100) for all testing before and 
after your knee surgery.  
 
Upon arrival to the Gait Lab, you will be asked to fill out one survey in reference to 
your current pain and activity level. 
 
When you arrive at the Gait Lab measurements about your body will be taken and 
you will be asked to perform the following tasks:  
(1) walk for 6 meters at a comfortable speed 6-10 times (Gait Analysis),  
(2) walking up and down stairs at a comfortable speed 3-4 times, and  
(3) push into stationary objects (fixed dynamometer) with your leg for three 
seconds for two different leg movements (Isometric Strength).   
You will also be asked some questions about your daily activities. The entire visit 
will take approximately 60 minutes.   
 
You will be asked to go to the Gait Lab for your first study visit before your surgery.  
Each visit to the Gait lab will take approximately 60 minutes.  You will be asked to 
return to the Gait Lab four more times over the next one year to repeat the 
procedures listed above (please see Table 1 below for visit schedule). 
 
Table 1.  Visit Time Line 
 
 Before 
Surgery 
6 Weeks 
After 
Surgery 
3 Months 
After 
Surgery 
6 Months 
After 
Surgery 
1 Year 
After 
Surgery 
Gait  
Analysis (test) 
X X X X X 
Isometric 
Strength 
X X X X X 
Survey X X X X X 
 
 
 
RISKS AND DISCOMFORTS 
 
There are risks associated with your knee replacement surgery.  These include: 
- Blood clots that can, in rare cases, be life threatening 
- Complications after a blood transfusion 
- Allergic reaction to the medications or materials used 
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- Injury to arteries in your leg 
- Surgery may not reduce your pain and stiffness, possibly requiring more 
treatment 
- Surgery may cause more pain 
 
Due to the level of physical activity involved, there is a risk of injury.  You may have 
pain in your affected joint during testing.  You may also have some discomfort, 
muscle cramping or soreness during or after test sessions.  Although we have people 
to assist you and handrails in place, there is a chance of falling during the test.  
There is a very remote chance of cardiac arrest and/or death.  These risks are 
comparable to your routine rehabilitation and activities of daily living, and will not 
affect your recovery from the surgery. 
 
You cannot participate in this study if you are pregnant because the information 
collected during the walking test may not accurately represent your normal walking 
characteristics.  If you are unaware that you are pregnant, participation in this study 
will result in no more danger to the mother or fetus than normal activities of daily 
living.  However, if you become pregnant or think you might be pregnant during the 
course of this study, you must inform the researchers, and you will be excluded from 
study participation. 
 
NEW INFORMATION 
 
You will be told about anything new that might change your decision to be in this 
study.  You may be asked to sign a revised consent form if this occurs. 
 
BENEFITS 
 
You may not receive direct/immediate benefits.  However, you will obtain 
information regarding your walking gait, functional activity capacity, hip muscular 
strength, and behavioral characteristics.  Results of this study may assist physicians, 
physical therapists, and athletic trainers to ensure the optimal clinical outcomes to 
maintain the beneficial effects of knee replacement. 
 
PAYMENT FOR PARTICIPATION 
 
You will be given $5 that can be applied towards parking and/or transportation to 
the University of Hawaii Gait Laboratory each time you come for a visit.  The money 
will be given to you after you arrive to the facility so it is a reimbursement.  If you do 
not finish the study, you will be paid only for the visits you have completed. 
 
COSTS 
 
There are no additional costs related to the procedures and visits that may result 
from your participation in this research study.   
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Any costs associated with parking/transportation over and above the $5 provided 
will be your responsibility.  The fee for parking at the University of Hawaii parking 
structure is $5 during the week and $6 on the weekends. 
 
ALTERNATIVE TREATMENT 
 
Your alternative is not to participate in this study.   
 
USE AND DISCLOSURE OF YOUR HEALTH INFORMATION: 
 
By signing this form, you are authorizing the use and disclosure of individually 
identifiable information.  Your information will only be used/disclosed as described 
in this consent form and as permitted by state and federal laws.  If you refuse to give 
permission, you will not be able to be in this research. 
 
This consent covers all information about you that is used or collected for this study.  
It includes 
• Past and present medical records 
• Research records 
• Records about your study visits. 
• Information gathered for this research about: 
Physical exams 
Laboratory, x-ray, and other test results 
Questionnaires 
• Records about the implanted medical device. 
 
Your authorization to use your identifiable health information will not expire even if 
you terminate your participation in this study or you are removed from this study 
by the study doctor.  However, you may revoke your authorization to use your 
identifiable information at anytime by submitting a written notification to the 
principal investigator, Cass Nakasone, MD at 888 S. King Street, Honolulu, HI 96813.  
If you decide to revoke (withdraw or “take back”) your authorization, your 
identifiable health information collected or created for this study shall not be used 
or disclosed by the study doctor after the date of receipt of the written revocation 
except to the extent that the law allows us to continue using your information.  The 
investigators in this study are not required to destroy or retrieve any of your health 
information that was created, used or disclosed for this study prior to receiving your 
written revocation.    
 
 
 
By signing this consent form you authorize the following parties to use and or 
disclose your identifiable health information collected or created for this study: 
• Cass Nakasone, MD and his research staff for the purposes of conducting this 
research study.  
55 
 
• Straub Medical Center and Hawai‘i Pacific Health 
• The University of Hawai‘i  
 
Your medical records may contain information about AIDS or HIV infection, venereal 
disease, treatment for alcohol and/or drug abuse, or mental health or psychiatric services. 
By signing this consent form, you authorize access to this information if it is in the 
records used by members of the research team.   
 
The individuals named above may disclose your medical records, this consent form 
and the information about you created by this study to: 
• The sponsor of this study and their designees (if applicable) 
• Federal, state and local agencies having oversight over this research, such as 
the Office for Human Research Protections in the U.S. Department of Health 
and Human Services, Food and Drug Administration, the National Institutes 
of Health, etc. 
• The University of Hawai‘i 
• Hawaii Pacific Health (HPH) Officials, the Western Institutional Review 
Board, and the HPH Office of Compliance for purposes of overseeing the 
research study and making sure that your ethical rights are being protected. 
 
Some of the persons or groups that receive your study information may not be 
required to comply with federal privacy regulations, and your information may lose 
its federal privacy protection and your information may be disclosed without your 
permission.  
 
COMPENSATION FOR INJURY 
 
In the event of any physical injury from the research, only immediate and essential 
medical treatment is available.  First Aid/CPR and a referral to a medical emergency 
room will be provided.  In the event of any emergency incidence outside the lab as a 
result of this research, contact your medical doctor and inform the study 
coordinator:  Cris Stickley Ph.D., ATC, at 808-956-3798.  You should understand that 
if you are injured in the course of this research process that you or your medical 
insurance will be billed for the costs of treating your injuries. 
 
VOLUNTARY PARTICIPATION AND WITHDRAWAL 
 
Your participation in this study is voluntary.  You may decide not to participate or 
you may leave the study at any time.  Your decision will not result in any penalty or 
loss of benefits to which you are entitled. 
 
Your participation in this study may be stopped at any time by the study doctor or 
the sponsor without your consent for any of the following reasons: 
• it is in your best interest; 
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• you do not consent to continue in the study after being told of changes in the 
research that may affect you; 
• you become pregnant; 
• or for any other reason. 
 
If you leave the study before the planned final visit, you may be asked by the study 
doctor to have some of the end of study procedures done. 
 
SOURCE OF FUNDING FOR THE STUDY 
 
This research study is sponsored by the University of Hawai‘i at Manoa. 
 
QUESTIONS 
 
Contact Cris Stickley Ph.D., ATC at 808-956-3798 or Dr. Cass Nakasone at 808-522-
4232 for any of the following reasons: 
• if you have any questions about this study or your part in it 
• if you feel you have had a research-related injury or 
• if you have questions, concerns or complaints about the research 
 
If you have questions about your rights as a research subject or if you have 
questions, concerns or complaints about the research, you may contact: 
 
 Western Institutional Review Board® (WIRB®) 
 1019 39th Avenue SE Suite 120 
 Puyallup, WA 98374-2115 
 Telephone:  1-800-562-4789 or 360-252-2500 
 E-mail: Help@wirb.com. 
 
 
WIRB is a group of people who perform independent review of research. 
 
WIRB will not be able to answer some study-specific questions, such as questions 
about appointment times.  However, you may contact WIRB if the research staff 
cannot be reached or if you wish to talk to someone other than the research staff. 
 
Do not sign this consent form unless you have had a chance to ask questions and 
have gotten satisfactory answers. 
 
If you agree to be in this study, you will receive a signed and dated copy of this 
consent form for your records. 
 
 
CONSENT 
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I have read this consent form.  All my questions about the study and my part in it 
have been answered.  I freely consent to be in this research study. 
 
I authorize the use and disclosure of my health information to the parties listed in 
the authorization section of this consent for the purposes described above. 
 
By signing this consent form, I have not given up any of my legal rights. 
 
 
  
Subject Name (printed) 
 
CONSENT SIGNATURE: 
 
 
    
Signature of Subject Date 
 
 
    
Signature of Person Conducting Informed Consent Discussion Date 
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RESEARCH SUBJECT INFORMATION AND CONSENT FORM 
 
TITLE: Biomechanical Comparison of Multi- and Single Radius Implant Designs During Level 
Walking and Stair Climbing Tasks 
 
PROTOCOL NO.:  2014-018  
 WIRB® Protocol #20141194 
 
SPONSOR: Cris Stickley, PhD, ATC 
 
INVESTIGATOR: Cass Nakasone, MD 
 888 South King Street 
  Honolulu, Hawaii 96813 
 United States 
 
SITE(S): University of Hawaii at Manoa 
 PE/A Complex Room 231, Lower Campus Road 
  Honolulu, Hawaii 96822 
 United States 
 
 Straub Clinic & Hospital 
 888 S. King Street 
  Honolulu, Hawaii 96813 
 United States 
 
STUDY-RELATED 
PHONE NUMBER(S): Cass Nakasone, M.D. 
808-522-4232 
 
 Cris Stickley PhD, ATC  
808-956-3798 
 
This consent form may contain words that you do not understand.  Please ask the study 
doctor or the study staff to explain any words or information that you do not clearly 
understand.  You may take home an unsigned copy of this consent form to think about or 
discuss with family or friends before making your decision. 
 
SUMMARY 
 
You are being asked to be in a research study.  The purpose of this consent form is to 
help you decide if you want to be in the research study.  Please read this consent form 
carefully.  To be in a research study you must give your informed consent.  “Informed 
consent” includes: 
• Reading this consent form 
• Having the study doctor or study staff explain the research study to you 
• Asking questions about anything that is not clear, and 
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• Taking home an unsigned copy of this consent form.  This gives you time to think 
about it and to talk to family or friends before you make your decision. 
 
You should not join this research study until all of your questions are answered. 
 
Things to know before deciding to take part in a research study: 
• The main goal of a research study is to learn things to help patients in the future. 
• The main goal of regular medical care is to help each patient. 
• No one can promise that a research study will help you. 
• Taking part in a research study is entirely voluntary.  No one can make you take 
part. 
• If you decide to take part, you can change your mind later on and withdraw from 
the research study. 
• The decision to join or not join the research study will not cause you to lose any 
medical benefits.  If you decide not to take part in this study, your doctor will 
continue to treat you. 
• Parts of this study may involve standard medical care.  Standard care is the 
treatment normally given for a certain condition or illness. 
• After reading the consent form and having a discussion with the research staff, 
you should know which parts of the study are experimental (investigational) and 
which are standard medical care. 
• Your medical records may become part of the research record.  If that happens, 
your medical records may be looked at and/or copied by the sponsor of this study 
and government agencies or other groups associated with the study. 
 
After reading and discussing the information in this consent form you should know: 
• Why this research study is being done; 
• What will happen during the research; 
• Any possible benefits to you; 
• The possible risks to you; 
• How problems will be treated during the study and after the study is over. 
 
If you take part in this research study, you will be given a copy of this signed and dated 
consent form. 
 
PURPOSE OF THE STUDY 
 
The purpose of this study is to compare the function of patients, implanted with either a 
multi-radii or a single radius total knee arthroplasty design, during level walking and stair 
climbing tasks.  You are being asked to participate in this study because you are 
undergoing total knee arthroplasty.  About 100 subjects are expected to participate. 
 
PROCEDURES 
 
If you decide to participate in this study, you will be randomly assigned (by chance) to 
one of four possible groups and receive either a single radius knee implant or one of three 
multiple radii knee implants.  You have an equal chance of being assigned to any one of 
the four implant groups. The implants that will be used in this study are: 
60 
 
• GetAroundKnee™, Stryker Orthopedics (single radius) 
• Balanced Knee® System, Ortho Development (multiple radii), 
• Persona ™ Total Knee, Zimmer (multiple radii) 
• NexGen®, Zimmer (multiple radii) 
 
These types of implants are approved by the FDA for the type of surgery you are having 
and will be used according to their approved indication. 
 
You will be asked to report to the University of Hawaii at Manoa, Kinesiology and 
Rehabilitation Science Laboratory (Gait Lab) (Sherriff 100) for all testing visits before 
and after your knee surgery.  
 
Upon arrival to the Gait Lab, you will be asked to fill out one survey in reference to your 
current pain and activity level. Measurements about your body will be taken and you will 
be asked to perform the following tasks:  
(1) walk for 6 meters at a comfortable speed 6-10 times (Gait Analysis),  
(2) walking up and down stairs at a comfortable speed 3-4 times, and  
(3) push into stationary objects (fixed dynamometer) with your leg for three seconds for 
two different leg movements (Isometric Strength).   
 
You will also be asked some questions about your daily activities. The entire visit will 
take approximately 60 minutes.   
 
You will be asked to go to the Gait Lab for your first study visit before your surgery. You 
will be asked to return to the Gait Lab 5 more times over the next two years to repeat the 
procedures listed above (please see Table 1 below for visit schedule). Each visit to the 
Gait lab will take approximately 60 minutes. 
 
Table 1.  Visit Time Line 
 Before 
Surgery 
6 Weeks 
After 
Surgery 
3 Months 
After 
Surgery 
6 Months 
After 
Surgery 
1 Year 
After 
Surgery 
2 Years 
After 
Surgery 
Gait  
Analysis (test) 
X X X X X X 
Isometric 
Strength 
X X X X X X 
Paper/Pencil 
Survey 
X X X X X X 
 
RISKS AND DISCOMFORTS 
Being randomized to one type of knee implant instead of the others, may lead to greater 
or lesser stability of the knee post-surgery. 
 
There are risks associated with your knee replacement surgery, whether or not you 
participate in this study.  These include: 
• Blood clots that can, in rare cases, be life threatening 
• Complications after a blood transfusion 
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• Allergic reaction to the medications or materials used 
• Infection 
• Injury to arteries or nerves in your leg 
• Surgery may not reduce your pain and stiffness, possibly requiring more treatment 
• Surgery may cause more pain 
• Risks of anesthesia  
 
You will be asked to review and sign a separate consent form for your knee surgery, and 
your surgeon will explain the risks of the procedure in more detail.  
 
Gait analysis risks 
Due to the level of physical activity involved during the testing procedures, there is a risk 
of injury.  You may have pain in your affected joint during testing.  You may also have 
some discomfort, muscle cramping or soreness during or after test sessions.  Although we 
have people to assist you and handrails in place, there is a chance of falling during the 
test.  There is a very remote chance of cardiac arrest and/or death.  These risks are 
comparable to your routine rehabilitation and activities of daily living, and will not affect 
your recovery from the surgery. 
 
You cannot participate in this study if you are pregnant because the information collected 
during the walking test may not accurately represent your normal walking 
characteristics.  If you are unaware that you are pregnant, participation in this study will 
result in no more danger to the mother or fetus than normal activities of daily living.  
However, if you become pregnant or think you might be pregnant during the course of 
this study, you must inform the researchers, and you will be removed from study 
participation. 
 
NEW INFORMATION 
 
You will be told about anything new that might change your decision to be in this 
study.  You may be asked to sign a revised consent form if this occurs. 
 
BENEFITS 
 
You may not receive direct/immediate benefits from study participation.  However, you 
will obtain information regarding your walking gait, functional activity capacity, hip 
muscular strength, and behavioral characteristics.  Results of this study may assist 
physicians, physical therapists, and athletic trainers to ensure the optimal clinical 
outcomes to maintain the beneficial effects of total knee replacement. 
 
PAYMENT FOR PARTICIPATION 
 
You will not be paid for your participation in the study.  
 
You will be given $5 that can be applied towards parking and/or transportation to the 
University of Hawaii Gait Laboratory each time you come for a visit.  The money will be 
given to you after you arrive at the facility with a receipt, so it is a reimbursement.  You 
will be reimbursed only for the visits that you attend. 
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COSTS 
 
You are not expected to have additional costs related to the procedures and visits that 
may result from your participation in this research study. 
 
Any additional costs associated with parking/transportation over and above the $5 
provided will be your responsibility.  The fee for parking at the University of Hawaii 
parking structure is $5 during the week and $6 on the weekends. 
 
ALTERNATIVE TREATMENT 
 
If you decide not to participate in this study, you will receive your knee replacement 
surgery with the type of implant that your doctor feels is best for you. Your follow-up 
care will be the same whether or not you are in this study. 
 
USE AND DISCLOSURE OF YOUR HEALTH INFORMATION: 
By signing this form you are authorizing the use and disclosure of individually 
identifiable information.  Your information will only be used/disclosed as described in 
this consent form and as permitted by state and federal laws.  If you refuse to give 
permission, you will not be able to be in this research. 
 
This consent covers all information about you that is used or collected for this study.  It 
includes 
• Past and present medical records 
• Research records 
• Records about your study visits. 
• Information gathered for this research about: 
Physical exams 
Laboratory, x-ray, and other test results 
Questionnaires 
• Records about the implanted medical device. 
 
Your authorization to use your identifiable health information will not expire even if you 
terminate your participation in this study or you are removed from this study by the study 
doctor.  However, you may revoke your authorization to use your identifiable information 
at any time by submitting a written notification to the principal investigator, Cass 
Nakasone, MD at 888 S. King Street, Honolulu, HI 96813.  If you decide to revoke 
(withdraw or “take back”) your authorization, your identifiable health information 
collected or created for this study shall not be used or disclosed by the study doctor after 
the date of receipt of the written revocation except to the extent that the law allows us to 
continue using your information.  The investigators in this study are not required to 
destroy or retrieve any of your health information that was created, used or disclosed for 
this study prior to receiving your written revocation.  
 
By signing this consent form you authorize the following parties to use and or disclose 
your identifiable health information collected or created for this study: 
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• Cass Nakasone, MD and his research staff for the purposes of conducting this 
research study.  
• Straub Clinic & Hospital and Hawai‘i Pacific Health 
 
Your medical records may contain information about AIDS or HIV infection, venereal 
disease, treatment for alcohol and/or drug abuse, or mental health or psychiatric services. 
By signing this consent form, you authorize access to this information if it is in the 
records used by members of the research team.   
 
The individuals named above may disclose your medical records, this consent form and 
the information about you created by this study to: 
• The sponsor of this study and their designees (if applicable) 
• Federal, state and local agencies having oversight over this research, such as the 
Office for Human Research Protections in the U.S. Department of Health and 
Human Services, Food and Drug Administration, the National Institutes of 
Health, etc. 
• The University of Hawai‘i 
• Hawaii Pacific Health (HPH) Officials, the Western Institutional Review Board, 
and the HPH Office of Compliance for purposes of overseeing the research study 
and making sure that your ethical rights are being protected. 
 
Some of the persons or groups that receive your study information may not be required to 
comply with federal privacy regulations, and your information may lose its federal 
privacy protection and your information may be disclosed without your permission.  
 
COMPENSATION FOR INJURY 
 
In the event of any physical injury from the research, only immediate and essential 
medical treatment is available.  First Aid/CPR and a referral to a medical emergency 
room will be provided.  In the event of any emergency incidence outside the lab as a 
result of this research, contact your regular medical doctor and inform the study 
coordinator:  Cris Stickley Ph.D., ATC, at 808-956-3798.  You should understand that, if 
you are injured in the course of this research process, you or your medical insurance will 
be billed for the costs of treating your injuries. 
 
VOLUNTARY PARTICIPATION AND WITHDRAWAL 
 
Your participation in this study is voluntary.  You may decide not to participate or you 
may leave the study at any time.  Your decision will not result in any penalty or loss of 
benefits to which you are entitled. 
 
Your participation in this study may be stopped at any time by the study doctor or the 
sponsor without your consent for any of the following reasons: 
• it is in your best interest; 
• you do not consent to continue in the study after being told of changes in the 
research that may affect you; 
• you become pregnant; 
• or for any other reason. 
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If you leave the study before the planned final visit, you may be asked by the study 
doctor to have some of the end of study procedures done. 
 
SOURCE OF FUNDING FOR THE STUDY 
 
This research study is sponsored by the University of Hawaii, Manoa. 
 
QUESTIONS 
 
Contact Cris Stickley Ph.D., ATC at 808-956-3798 or Dr. Cass Nakasone at 808-522-
4232 for any of the following reasons: 
• if you have any questions about this study or your part in it 
• if you feel you have had a research-related injury or 
• if you have questions, concerns or complaints about the research 
 
If you have questions about your rights as a research subject or if you have questions, 
concerns, input, or complaints about the research, you may contact: 
 
 Western Institutional Review Board® (WIRB®) 
 1019 39th Avenue SE Suite 120 
 Puyallup, Washington 98374-2115 
 Telephone:  1-800-562-4789 or 360-252-2500 
 E-mail: Help@wirb.com. 
 
WIRB is a group of people who perform independent review of research. 
 
WIRB will not be able to answer some study-specific questions, such as questions about 
appointment times.  However, you may contact WIRB if the research staff cannot be 
reached or if you wish to talk to someone other than the research staff. 
 
Do not sign this consent form unless you have had a chance to ask questions and have 
gotten satisfactory answers. 
 
If you agree to be in this study, you will receive a signed and dated copy of this consent 
form for your records. 
 
CONSENT 
 
I have read this consent form.  All my questions about the study and my part in it have 
been answered.  I freely consent to be in this research study. 
 
I authorize the use and disclosure of my health information to the parties listed in the 
authorization section of this consent for the purposes described above. 
 
By signing this consent form, I have not given up any of my legal rights. 
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Subject Name (printed) 
 
CONSENT SIGNATURE: 
 
________________________________________________________________  
Signature of Subject Date 
 
________________________________________________________________  
Signature of Person Conducting Informed Consent Discussion Date 
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APPENDIX B: ACTIVITY ASSESSMENT SURVEY 
 
UCLA ACTIVITY SCALE 
Subject ID#: _______________ Data Collection Period 0 1 2 3 4 5 6 7  
Please circle the number that best describes current activity level.  
1. Wholly inactive, dependent on others, and can not leave residence   
2. Mostly inactive or restricted to minimum activities of daily living   
3. Sometimes participates in mild activities, such as walking, limited housework and 
limited shopping   
4. Regularly participates in mild activities   
5. Sometimes participates in moderate activities such as swimming or could do unlimited 
housework or shopping   
6. Regularly participates in moderate activities   
7. Regularly participates in active events such as bicycling   
8. Regularly participates in active events, such as golf or bowling   
9. Sometimes participates in impact sports such as jogging, tennis, skiing, acrobatics, 
ballet, heavy labor or backpacking   
10. Regularly participates in impact sports   
Please circle the number that best answers the following question.  “How does your knee 
affect your ability to rise form a chair?”: 
 
1. “Because of my knee I cannot rise from a chair.” 
 
2. “Because of my knee, I can only rise from a chair if I use my hands and arms to 
assist.” 
 
3. “I have pain when rising from the seated position, but it does not affect my ability 
to rise from the seated position.” 
 
4. “My knee does not affect my ability to rise from a chair.” 
 
Are you satisfied with your implant?        YES  NO 
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APPENDIX C: DATA COLLECTION FORMS 
 
 
Anthropometric Data  
Subject ID#: _______________                                     Date_________  
Age________________                                                 Gender: F / M  
Data Collection Period 0 1 2 3 4 5  
Patient’s Operated leg: L / R                               Dominant Leg: L / R  
Date of Surgery_________________              
Weeks after Surgery________________  
Vicon/Nexus Measurements  
Weight (kg)  
Height (mm)  
Age (yrs)  
Left leg length (mm)  
Left knee width (mm)  
Left ankle width (mm)  
Right leg length (mm)  
Right knee width (mm)  
Right ankle width (mm)  
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DATA COLLECTION FORM 
 
Subject ID#: _______________   
Data Collection Period   0  1  2  3  4  5   
Patient’s Operated leg: L / R  Dominant leg: L / R 
 
Total Trials: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
 
Walking Trials 
Trial 
Which foot hit 
the plate 
Walking Pace 
(s) 
1 R / L  
2 R / L  
3 R / L  
 
 
Stair Ascent 
Trial 
Which foot hit 
the plate 
Walking Pace 
(s) 
1 R / L  
2 R / L  
3 R / L  
 
 
Stair Decent 
Trial 
Which foot hit 
the plate 
Walking Pace 
(s) 
1 R / L  
2 R / L  
3 R / L  
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Manual Muscle Testing Data Collection 
 
Subject ID#: _______________ Data Collection Period   0  1  2  3  4  5  6  7   
Patient’s Operated leg: L / R  Dominant Leg: L / R  
Tester: ______________________ 
 
 Left Leg Right Leg 
 
Trial 1 
Score 
(ft-lbf) 
Pain 
Score 
(HHD/Jt) 
Trail 2 
Score 
(ft-lbf) 
Pain 
Score 
(HHD/Jt) 
Trial 3 
Score 
(ft-lbf) 
Pain 
Score 
(HHD/Jt) 
Trial 1 
Score 
(ft-lbf) 
Pain 
Score 
(HHD/Jt) 
Trial 2 
Score 
(ft-lbf) 
Pain 
Score 
(HHD/Jt) 
Trial 3 
Score 
(ft-lbf) 
Pain 
Score 
(HHD/Jt) 
Hip 
abduction   
/ 
   
/ 
   
/ 
   
/ 
   
/ 
   
/ 
 
Knee 
extension   
/ 
   
/ 
   
/ 
   
/ 
   
/ 
   
/ 
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